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ABSTRACT OF THE DISSERTATION

Regulation of peripheral nerve regeneration by the mTOR pathway

by

NAMIKO ABE

While neurons in the central nervous system (CNS) have limited capacity for
regrowth after damage, neurons in the peripheral nervous system (PNS) have a robust
ability to regenerate their axons following injury. Successful regeneration depends upon
both extrinsic cues in the environment and the activation of intrinsic mechanisms to
promote regrowth. A number of inhibitory molecules in the CNS environment that
prevent axonal regrowth have been identified, but less is known regarding the signaling
mechanisms that regulate regenerative ability in PNS neurons. Here, we explored
multiple components of injury signaling in the PNS, including the retrograde transport of
local axonal injury signals, enhancement of axonal growth capacity in the cell body, and
the response of Schwann cells that myelinate the damaged axon.
We first addressed how axonal injury triggers enhancement of axonal growth
capacity in PNS neurons. The lack of regenerative ability of CNS neurons has been
linked to downregulation of the mammalian target of rapamycin (mTOR) pathway. We
find that PNS dorsal root ganglia neurons (DRGs) activate mTOR following damage, and
that this activity contributes to enhance axonal growth capacity following
injury. Furthermore, upregulation of mTOR activity by deletion of tuberous sclerosis
ii

complex 2 (TSC2) in DRGs is sufficient to enhance axonal growth capacity in vitro and
in vivo. We identified GAP-43 as a downstream target of this pathway, which may
contribute to enhance regenerative ability. However, while genetic upregulation of
mTOR activity in sensory neurons facilitates axonal regrowth, it also leads to a number
of developmental and functional defects, including aberrant target innervation. Thus,
while manipulation of the mTOR activity could stimulate nerve regeneration in the PNS,
fine control of mTOR activity may be required for proper target innervation and
functional recovery.
mTOR activation in the damaged neuron is likely to represent one of several
signaling events that mediate nerve regeneration. We thus also explored other aspects of
peripheral nerve injury signaling, including the retrograde transport of local injury signals
by axonal vesicles, and the response of myelinating Schwann cells to axonal damage.
Our results indicate that several classes of signaling pathways occurring both in axons
and Schwann cells cooperate to generate a robust regenerative response. A better
understanding of the signaling pathways leading to increased regenerative growth ability
of PNS neurons may guide new strategies to enhance nerve regeneration in the CNS.
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Chapter 1: Introduction- Nerve injury signaling

A modified version of this text appears in the manuscript:
Abe N and Cavalli V (2008) Nerve injury signaling. Curr Opin Neurobiol 18: 276-283.
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ABSTRACT
Although neurons within the peripheral nervous system (PNS) have a remarkable
ability to repair themselves after injury, neurons within the central nervous system (CNS)
do not spontaneously regenerate. This problem has remained recalcitrant despite a
century of research on the reaction of axons to injury. The balance between inhibitory
cues present in the environment and the intrinsic growth capacity of the injured neuron
determines the extent of axonal regeneration following injury. The cell body of an injured
neuron must receive accurate and timely information about the site and extent of axonal
damage in order to increase its intrinsic growth capacity and successfully regenerate. One
of the mechanisms contributing to this process is retrograde transport of injury signals.
For example, molecules activated at the injury site convey information to the cell body
leading to the expression of regeneration-associated genes and increased growth capacity
of the neuron. Here we discuss recent studies that have begun to dissect the injurysignaling pathways involved in stimulating the intrinsic growth capacity of injured
neurons.
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INTRODUCTION
The extremely polarized morphology of neurons (i.e. axon length extending for
up to 1 m) poses challenging problems for intracellular-signaling pathways. Information
about distant injury, for example, has to be communicated to the cell body to initiate a
proper regenerative response. Research on nerve regeneration has classically focused on
identifying the inhibitory factors present in the environment, which include the glial
scar and molecules such as Nogo and myelin-associated glycoprotein [1]. We know
much less about the mechanisms that activate the intrinsic growth capacity of neurons
following injury. Upon embryonic to adult transition, the intrinsic neuronal growth
activity is repressed to allow for proper synaptic development. Injury to adult peripheral
neurons, but not to central nervous system (CNS) neurons, reactivates the intrinsic
growth capacity and allows regeneration to occur. Primary sensory neurons
with cell bodies in the dorsal root ganglion (DRG) provide a useful model system to
study the mechanisms that regulate regeneration. DRG neurons are pseudobipolar
neurons and possess two axonal branches: a peripheral axon that regenerates when
injured and a centrally projecting axon that does not regenerate following
injury. Remarkably, injury to the peripheral branch before injury to the central branch
promotes regeneration of central axons [2] [3]. This phenomenon is referred to as the
‘conditioning lesion’ paradigm (Figure 1) and indicates that retrograde injury signals
travel from the peripheral injury site back to the cell body to increase the intrinsic growth
capacity of the neuron. An increased intrinsic growth state as a result of a preconditioning
lesion may enable centrally injured axons to regenerate. A series of elegant studies in the
early 1990s in the mollusk Aplysia californica provided evidence for the existence of
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multiple injury signals functioning in a temporal sequence [4]: injury-induced discharge
of axonal potentials, interruption of the normal supply of retrogradely transported targetderived factors (also called negative injury signals) and retrograde injury signals traveling
from the injury site back to the cell body (also called positive injury signals) (Figure 2).
The retrograde transport of injury signals is one of the essential cellular
mechanisms leading to regeneration. Coordination between several injury-signaling
pathways is necessary to regulate the appropriate genes to promote neuronal survival and
increase the intrinsic growth state of injured neurons. In this thesis, we depart from the
traditional focus on inhibitory factors in the non-regenerating CNS, and focus on
signaling mechanisms leading to the enhanced intrinsic growth capacity of peripheral
neurons following injury.

Injury signaling in the axon
Positive injury signals
The positive injury signals identified thus far cover a broad array of functionally
distinct proteins that include members of the mitogen-activated protein kinase family
(MAPK), cytokines, and their downstream transcription factors, as well as locally
translated importin, a main regulator of nuclear import and export. Axonal transport of
several kinases was initially suggested to play a role in relaying information from the
nerve terminal to the cell body [5]. It is now known that axonal injury induces local
activation and retrograde transport of several MAPKs, including Erk [6] [7], the c-Jun Nterminal kinase (JNK) [8] [9], and the protein kinase G [10]. These studies strongly
suggest that activation of kinases, in particular JNK and Erk and their interaction with the
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dynein/dynactin retrograde molecular motors is required for regeneration [6] [8]. Indeed,
deletion of JNK2 or JNK3 leads to defects in axonal outgrowth in response to
dissociation [8]. Transport of such injury signal is complicated by the fact that many
kinases including JNK and Erk are activated by reversible phosphorylation and without
proper protection this signal may not persist [11].
A key question then is how to prevent deactivation of the signal during the long
journey to the cell body. One elegant solution is to protect the signal with scaffolding
proteins. For example, it has been recently shown that the intermediate filament vimentin
interacts with phosphorylated Erk1 to protect it from dephosphorylation by calciumdependent steric hindrance [12]. Another mechanism proposed to protect
dephosphorylation is storage within intraluminal vesicles of multivesicular bodies [13].
Indeed, kinases such as JNK can hitchhike on axonal vesicles [8] and intraluminal
vesicles are not always destined to lysosomes for degradation; they can also fuse back
with the limiting membrane of late endosomes [14]. This process is hijacked by several
toxins and viruses to reach the cell body and could similarly be exploited by signaling
proteins. Combined with a protection mechanism against phosphatases during transport,
activation and retrograde transport of MAPKs might play an important role in
regeneration. The upstream signaling cascade leading to MAPK activation in the axon
remains yet to be established.
In addition to MAPK, axonal injury activates several transcription factors through
the local release of cytokines. These include the gp130 cytokines leukemia inhibitory
factor (LIF), interleukein-6 (IL-6), and ciliary neurotrophic factor (CNTF). LIF and IL-6
are required for the increased growth state of DRG neurons following peripheral injury
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through activation of downstream genes such as GAP43 [15] [16], although Cao et al.
[17] reported that IL-6 knockout animals do not show defects in nerve regeneration.
Upregulation of IL-6 in DRG cell bodies themselves following injury [17] [18] [19]
raises the possibility of paracrine or autocrine action of IL-6, which may amplify a
cytokine-induced retrograde signal. The gp130 cytokines signal through a common
receptor, gp130, and the JAK-STAT pathway, which leads to STAT3 phosphorylation
and translocation into the nucleus [20]. Although retrograde transport of locally activated
STAT3 has been suggested [21] [22], in vitro studies using compartmentalized cultures
suggest a signaling endosome model in which the gp130/JAK complex is endocytosed
and retrogradely transported to activate STAT3 in the cell body [23]. Interestingly,
STAT3 activation through the Jak2-signaling pathway occurs in DRG neurons cell body
after peripheral, but not central, lesion [24] [25], strongly supporting a role for STAT3 in
neuronal regeneration. Although STAT3 signaling promotes axonal regrowth, in vitro
studies showed that suppressor of cytokine signaling (SOCS3) inhibits STAT3 [26] and
SOCS3 levels are increased by peripheral injury [27]. Although the influence of
endogenous SOCS3 on axonal growth in peripheral neurons may be limited, SOCS3 may
contribute to the lack of regeneration in CNS neurons [26]. Indeed, deletion of SOCS3 in
retinal ganglion cells promotes regeneration [28]. The pathways leading to STAT3
activation are partially understood but the downstream targets of the cytokine-STAT3
signaling remain to be clearly defined.
Work over the past ten years has confirmed that axons have the capacity to locally
synthesize proteins [29]. Axonal mRNA translation plays a role in axonal growth during
development [29]and mature neurons use axonal mRNA translation to transfer injury
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signals to the nucleus of injured neurons. Following peripheral nerve injury, de novo
synthesis of importin-beta [7]and vimentin [6] leads to the formation of an importinactivated Erk–vimentin complex that recruits the retrograde motor dynein, linking the
nuclear import machinery to retrograde injury signaling. Since a surprisingly large
population of mRNAs localizes to sensory axons [30], future studies will reveal the
possible role for other de novo synthesized proteins in injury signaling.
The positive injury signals identified so far share one common theme:
microtubule-dependent retrograde transport. In chapter 4, we examine the localization
and transport properties of axonal vesicles that contain Sunday Driver, a scaffolding
protein that links active JNK molecules with axonal transport [8]. Future studies may
identify new molecules involved in injury signaling and elucidate how these signals
interact with the axonal transport machinery. It is tempting to speculate that the
combination of several positive injury signals might serve as an indicator of the extent
and nature of damage.

Negative injury signals
Although loss of negative cues represents another important mechanism to sense
injury, surprisingly little is known about this type of signaling. Once a neuron is
connected with its target, target-derived signals must repress the intrinsic neuronal
growth activity to allow for proper synaptic development. This repression has to be
relieved to allow regeneration to occur. Although neurotrophins represent the ideal
candidates, evidence for their role as negative signals following injury have not yet been
established.
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One recently identified negative injury signal is the TGF beta/SMAD2/SMAD3
pathway (personal communication with Zhigang He). SMAD2 is downregulated
following peripheral nerve injury, indicating that SMAD2-dependent gene transcription
may restrict the axonal growth ability in healthy neurons and injury may relieve this
inhibition. Whether SMAD2/SMAD3 contributes to the decreased regenerative ability of
adult CNS neurons remains to be determined. The transcription factor ATF-2 is also
rapidly suppressed in neurons following injury [31]. Similarly to SMAD2, ATF2dependent gene transcription may repress neuronal growth capacity. Future studies are
needed to explore the role of negative injury signals in axonal regeneration.

Electrical activity
Recent data suggest an important role of neural activity in regeneration. The
transection of axons initiates a large depolarizing voltage discharge that travels back to
the soma and triggers vigorous spiking activity and sustained depolarization [32]. This
extensive electrical activity produces a strong calcium influx in both the axon and the
soma. Propagation of this response requires the activation of voltage-gated sodium
channels and is necessary for regeneration, since axotomy in the presence of tetrodotoxin
reduces the regenerative process [32]. Calcium influx is also necessary for regeneration
in vitro and is likely to act through protein kinases such as ERK or PKA [33]. In vivo
studies showed that electrical stimulation accelerates motor [34] and sensory [35] axon
outgrowth and increases intracellular cAMP levels in DRG neurons as effectively as the
conditioning lesion [35]. However, electrical stimulation did not recapitulate all
characteristics of axonal outgrowth, indicating that cAMP alone is not sufficient to
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trigger a complete regenerative response [35]. In marked contrast, electrical stimulation
of CNS axons does not promote regeneration, even when provided a permissive growth
environment through a peripheral nerve graft [36]. Electrical activity thus may play an
important role as an early injury signal in the peripheral nervous system (PNS), but might
be insufficient to initiate regeneration of CNS neurons.

Signaling mechanisms in CNS axons
Induction of retrograde injury signals has so far been demonstrated in peripheral
neurons. Recent studies in CNS neurons of the retina have unravelled the existence of
parallel mechanisms between CNS and PNS neurons and demonstrated that the growth
capacity of CNS neurons can be enhanced. While retinal ganglion cells (RGCs) normally
fail to regenerate their injured axons, lens injury activates macrophages and stimulates
regeneration of RGCs [37]in a process that resemble the conditioning injury in DRG
neurons. Soluble factors released by activated macrophages, such as oncomodulin, are
sufficient to promote RGC regeneration through a Ca2+/calmodulin-dependent pathway
[37]. While oncomodulin promotes neurite outgrowth in cultured central and peripheral
neurons [38], its role in sensory nerve regeneration has yet to be explored in vivo. Lens
injury also induces upregulation of CNTF in retinal astrocytes, a process that is
independent of macrophages, and leads to STAT3 activation in RGCs [39] [40]. The
cytokine-mediated activation of STAT3 is a central injury signaling mechanism in PNS
neurons, suggesting another possible parallel between the responses of CNS and PNS
neurons to injury.
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A separate study in RGCs have shown that downregulation of an intrinsic growth
pathway is linked to their poor regenerative ability. RGC neurons show a developmental
decline in mTOR activity, which correlates with their decreased growth capacity [41].
Furthermore, axotomy to RGCs leads to a further downregulation of mTOR activity [41].
Remarkably, activation of mTOR by genetic deletion of the upstream negative regulators
PTEN or TSC1 promotes regeneration in these normally non-regenerating central
neurons [41]. In chapter 2, we examine whether the mTOR pathway is activated in
peripheral neurons following injury, and whether this pathway contributes to enhance
axonal growth capacity.
Similarly, transcriptional repression is linked to the downregulation of intrinsic
growth capacity in RGCs. RGCs show a developmental increase in the expression of
Kruppel-like factor-4 (KLF4), a transcriptional repressor, which is correlated with the
decline in growth ability [42]. Deletion of KLF4 in adult RGCs promotes regeneration
[42]. However, the KLF-4 target genes that regulate growth ability have not yet been
identified.
To elucidate molecular factors responsible for the poor regenerative capacity of
the CNS neurons, it will be important to determine whether CNS neurons lack the ability
to activate or transport injury signals, are unable to relieve the growth inhibition brought
about during their maturation or are less responsive to cytokines and other injury induced
stimuli.

Somatic injury signaling
Role of cAMP
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Elevation of cAMP levels in the soma following axonal injury to peripheral
neurons contributes to the initiation of axonal regrowth [43]. cAMP not only increases
the growth capacity of injured neurons but also partly relieves CNS myelin inhibition.
The increase in cAMP levels appears to be transient and initiates a series of signaling
pathways involving PKA [44]. The effects of cAMP are transcription dependent [45] and
require the transcription factor cAMP response element binding protein (CREB) [46].
Interestingly, CREB mRNA is present in developing axons and CREB translation and
retrograde transport is triggered by the nerve growth factor (NGF) [47]. Whether CREB
translation plays a role in injury signaling in adult neurons remains to be determined.
Downstream targets of cAMP signaling include Arginase1, which mediates synthesis of
polyamines [48], neuropeptide Y, CREM (cAMP response element modulator), VGF
(NGF-inducible growth factor), and IL-6 [17] [19]. Some of these genes were also
identified in studies comparing the pattern of gene expression at different times after
sciatic nerve transection [27] [49], revealing a temporal hierarchy of gene activation
following injury. Although cAMP analogs fail to activate the intrinsic growth state of
RGCs [50] they potentiate the effect of lens injury [40], indicating that multiple pathways
act in parallel to stimulate RGCs regeneration. Although a direct link between retrograde
signaling in axons and elevation of cAMP in cell body of injured neurons is still lacking,
these results strongly suggest that the intrinsic growth capacity of the CNS neurons can
be enhanced under appropriate conditions.

Transcription factors
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Initiation of a regeneration program requires that retrograde signals from the
injury site alter transcription of multiple genes [45]. Members of the immediate-early
genes family, including c-Jun and JunD [51] [52], as well as members of the constitutive
transcription factors CREB, STAT3, SOX11, and ATF3 [24] [46] [53] [54] are elevated
and in some cases also activated in DRG cell bodies after peripheral injury. The
activation of c-Jun in the cell body is essential for the initiation of transcriptional changes
required for successful axonal regeneration. Some of the identified c-Jun-dependent
genes include integrin a7b1, CD44, and galanin [55]. Deletion of c-Jun in the nervous
system, while causing little effect on axonal growth during development, leads to a
marked defect in regeneration upon nerve transection [55]. The importance of c-Jun for
regeneration also comes from the observation that c-Jun activation in DRGs is drastically
greater following peripheral versus central branch axotomy [56] and c-Jun activation
persists until successful target reinnervation has been achieved [57] [58]. The time course
of c-Jun induction depends on the distance between the injury site and the cell body [57],
suggesting that JNK activation in the axon may lead to c-Jun expression in the cell body
[8] [9]. Similarly to c-Jun, ATF3, and STAT3 are induced in DRG neurons after
peripheral, but not central injury [24] [59]. Overexpression of ATF-3 in cultured neurons
enhances neurite outgrowth [59]and transgenic expression of ATF3 can partially
recapitulate a conditioning injury [60]. Conditional gene disruption of STAT3 indicates
that this gene may contribute to the survival of motor neurons after peripheral nerve
lesion through activation of motor neuron survival factors such as Reg-2 and Bcl-xl [61],
but a direct role on nerve regeneration per se has not been demonstrated. In vitro studies
show that another transcription factor Sox11 is expressed at high levels in developing and
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regenerating sensory neurons and regulates neurite outgrowth and cell survival [62].
Although the identity of the genes activated by injury is being unravelled, the overall
sequence and coordination of transcriptional events that initiate and sustain a
regeneration program awaits further studies.

Neurotrophic factors
Neurotrophic signaling is mostly known to play a role in neuronal survival during
development. The function of neurotrophins has been recently extended to other aspects
of neuronal function, including regeneration [63]. Upregulation of the glial-derived
neurotrophic factor GDNF and one of its receptors GFRa1 in injured nerves suggest that
GDNF provides neurotrophic support for injured DRG neurons [64]. GDNF delivery
directly to DRG cell bodies facilitates the conditioning injury induced growth promoting
effect [65]. Although GDNF and GFRa1 are retrogradely transported in peripheral axons
[66], a role of GDNF in injury signaling has not yet been examined. Fibroblast growth
factor-2 (FGF-2) is another neurotrophic factor contributing to nerve regeneration [67].
FGF-2 is upregulated following injury both at the lesion site and in the cell bodies of
peripheral nerves and transgenic mice overexpressing FGF2 show a greater increase in
the number of regenerating axons after sciatic nerve transection [68]. The presence of
neurotrophin signaling in injured nerve emphasizes the signaling crosstalk that is required
to promote neuronal survival and regeneration.

Support from Schwann cells
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Extrinsic factors in the environment interact with axonal injury signals for
successful regeneration. In the peripheral nervous system, Schwann cells play an
essential role in the maintenance of axon health and integrity in addition to providing
insulation for fast saltatory conduction of action potentials. In healthy nerves, the
relationship between axons and their myelinating Schwann cells is maintained by
contact-mediated reciprocal signaling [69]. Disruption of Schwann-cell-axon contact,
such as in the case of injury, activates a series of molecular and morphological changes in
Schwann cells [70]. These include dedifferentiation and demyelination, transfer of
ribosomes to axons, phagocytosis of axonal and myelin debris, synthesis of growth
factors and extracellular matrix proteins, and proliferation [70] [71]. Such Schwann-cell
mediated events play a critical role in the response of axons to injury and are discussed in
more detail in Chapter 5.

Conclusions
A single signaling pathway is unlikely to fully mediate nerve regeneration.
Several classes of injury signals may coexist to ensure precise information on the nature
of the damage and its distance from the cell body (Figure 3). It is tempting to speculate
that the difference in time between the arrival at the soma of the back propagating axonal
depolarization—the first injury signal, and the later arrival of a positive injury signal
might serve as an indicator of the distance of the injury site from the cell body.
Computational modeling analyses speculate that two signals-a rapid signal carried by
action potentials, and a slow signal carried by dynein-based transport-is sufficient to
estimate the distance between the injury site and the cell body [72]. However, a clear link
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between the arrival of injury signals and specific gene activation is still missing.
Ultimately, a direct comparison between injury-signaling mechanisms in CNS and PNS
neurons might shed light on the poor regenerative capacity of CNS neurons. This
knowledge will be essential to our understanding and ultimately treatment of many
debilitating CNS disorders, since in addition to traumatic axonal damage resulting from
spinal cord injury or stroke, axonal damage can also occur in many neurodegenerative
diseases in which axonal pathologies interrupt the cell body/synapse connection.
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Figure 1. Conditioning injury paradigm
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Figure 1. Conditioning injury paradigm. Primary sensory neurons within dorsal root
ganglia (DRG) are particularly useful to study axonal regeneration. DRG neurons are
unique in having two axonal branches; a long sensory CNS branch ascends the dorsal
column in the spinal cord and a second branch projects through a peripheral nerve.
Sensory axons in the adult spinal cord do not regenerate after injury (a), while peripheral
injury results in a robust regenerative response. Regeneration of the central branch can be
greatly enhanced by a prior injury to the peripheral branch, referred to as a ‘conditioning
injury’ (b). The conditioning injury suggests that distinct signaling mechanisms regulate
responses to central versus peripheral injury in DRG neurons and may contribute to their
different abilities to axonal regrowth.
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Figure 2. Injury signaling mechanisms
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Figure 2. Injury signaling mechanisms. The cell body of injured neurons must receive
accurate and timely information on the site and extent of axonal damage in order to
orchestrate an appropriate response leading to successful regeneration. Pioneering work
from the laboratories of Ambron and Walters have led to the notion that three distinct
signaling mechanisms may act in complementary and synergistic roles: (1) injuryinduced discharge of axonal potentials, (2) interruption of the normal supply of
retrogradely transported trophic factors or negative regulators of neuronal growth from
the target, and (3) retrograde transport of activated proteins emanating at the injury site,
termed positive injury signals.
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Figure 3. Activation of the intrinsic growth capacity by peripheral injury
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Figure 3. Activation of the intrinsic growth capacity by peripheral injury. Nerve
injury triggers multiple signaling events in the axon, including membrane depolarization,
JNK activation, mRNA translation, and cytokine-mediated STAT3 activation. These
events lead to the microtubule-based retrograde transport of signaling molecules back to
the cell body (shown by plain arrows). When these signaling molecules reach the cell
body, they mediate the expression of a number of transcription factors that regulate the
expression of genes involved in cell survival and neurite outgrowth. These downstream
targets also include some components of the injury signal, such as IL-6 and LIF, which
may amplify the injury signal via positive feedback.
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Chapter 2: mTOR activation increases axonal growth capacity of injured peripheral
nerves

Part of this work appears in the manuscript:
Abe N, Borson SH, Gambello MJ, Wang F, Cavalli V (2010) mTOR activation increases
axonal growth capacity of injured peripheral nerves. J Biol Chem. In press.
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ABSTRACT
Unlike neurons in the central nervous system (CNS), injured neurons in the
peripheral nervous system (PNS) can regenerate their axons and re-innervate their targets.
The lack of regenerative ability of CNS neurons has been linked to downregulation of the
mammalian target of rapamycin (mTOR) pathway. We report here that PNS dorsal root
ganglia neurons (DRGs) activate mTOR following damage, and that this activity
enhances axonal growth capacity. Furthermore, genetic upregulation of mTOR activity
by deletion of tuberous sclerosis complex 2 (TSC2) in DRGs is sufficient to enhance
axonal growth capacity in vitro and in vivo. We further report that mTOR activation
increases the expression of the growth-associated protein GAP-43, suggesting that
mTOR-dependent protein synthesis contributes to enhance regeneration of injured
peripheral neurons.
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INTRODUCTION
While neurons in the central nervous system (CNS) have limited capacity for
regrowth after damage, neurons in the peripheral nervous system (PNS) have a robust
ability to regenerate their axons following injury. However, functional recovery of
injured peripheral nerves often remains suboptimal, especially in cases of damage to a
significant length of a peripheral nerve. Successful regeneration depends upon both
extrinsic cues in the environment and the activation of intrinsic mechanisms to promote
re-growth. The glial environment of the adult CNS includes inhibitory factors that
prevent axon regrowth [1,2,3]. Components of the glial scar, which forms after CNS
injury, act as additional barriers to axon regeneration [4]. Furthermore, CNS neurons
display a decreased intrinsic capacity to regenerate, as removal of extracellular inhibitory
cues is not sufficient to promote successful regeneration [5,6,7,8]. Remarkably, genetic
deletion of all three major myelin inhibitors, Nogo, OMgp, and MAG does not promote
CNS regeneration [8].
Injured peripheral neurons benefit from the absence of inhibitory signals in their
environment, and in addition activate intracellular signaling pathways that enable axonal
regrowth. The ‘conditioning injury’ paradigm observed in dorsal root ganglia neurons
(DRGs) provides evidence for the existence of such intracellular signaling pathways
induced by injury, which enhance axonal growth capacity [9,10,11]. Injury to the sciatic
nerve several days prior to dissection allows affected DRG neurons to extend more
elongated, rapidly growing axons in culture compared to DRG neurons not subjected to a
conditioning injury [10]. This suggests that the robust response of peripheral axons to
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injury is not merely a ‘default’ state, but results from activation of injury signals to
increase axonal growth capacity.
Injury signals elicited both locally at the injury site and in the DRG cell bodies
increase the intrinsic growth capacity. Members of the MAPK family including JNK
[12,13], protein kinase G [14], and Erk1/Erk2 [15,16] are activated in injured axons and
retrogradely transported to the cell body, where they activate downstream effectors
required for regeneration. In DRGs cell bodies, transcription factors including c-Jun
[17,18], CREB [19], STAT3 [20] and ATF3 [21] are activated and initiate transcriptional
changes that contribute to regeneration. Despite the growing number of molecules
identified that play a role in regeneration, no single signaling pathway or transcription
factor alone has been shown to be sufficient for complete regeneration in the PNS,
suggesting that multiple pathways work in concert to maximize axonal growth capacity.
Recent evidence implicates the control of protein synthesis by the mTOR pathway
in the ability of neurons to regenerate. In non-neuronal cells, the mTOR pathway plays a
critical role in the regulation of cellular growth, proliferation, and survival during
development via the regulation of protein synthesis [22,23]. Upstream regulators of
mTOR include Akt and the TSC1/TSC2 complex, which sense the level of growth factors,
nutrients, ATP, and reactive oxygen species to either inhibit or activate mTOR [24]
(Figure 1). Activation of mTOR leads to the downstream phosphorylation of S6
ribosomal protein and 4EBP-1 to initiate protein translation [24] (Figure 1). The
developmental decline in mTOR activity observed in retinal ganglion cells correlates
with their decreased growth capacity [25]. Moreover, axotomy to retinal ganglion cells
leads to a further downregulation of mTOR activity [25]. Activation of mTOR by
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deletion of the upstream negative regulators PTEN or TSC1 promotes regeneration of
retinal ganglion cells, suggesting that mTOR activity is sufficient to increase growth
capacity in normally non-regenerating central neurons [25]. While inactivation of mTOR
activity is associated with decreased growth ability in the CNS, it is not yet known
whether this pathway is activated in the PNS after injury and whether it contributes to
increased axonal growth capacity.
In this study, we report that the mTOR pathway is activated in DRG neurons after
injury. Inhibition of mTOR activity by rapamycin partially blocks the conditioning
injury effect in DRGs, suggesting that mTOR activity contributes to the enhancement of
axonal growth capacity upon injury. Furthermore, deletion of TSC2, a negative regulator
of mTOR activity, leads to increased basal level of mTOR activity, which is sufficient to
mimic the conditioning injury-effect and enhance regeneration in vitro and in vivo. We
further report that mTOR activation increases the expression of the growth-associated
protein GAP-43, suggesting that mTOR-dependent increased protein synthesis
contributes to enhance regeneration of injured peripheral neurons.
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RESULTS
The mTOR pathway is activated in DRGs cell bodies following injury- To test
whether peripheral neurons upregulate the mTOR pathway following injury, we induced
sciatic nerve injury by ligation, then dissected and analyzed L4 and L5 DRGs one to four
days later. Phosphorylation of ribosomal S6 protein (S6), a downstream effector of
mTOR, was used as a marker for mTOR activity. One day following sciatic nerve
ligation, we observed a ~2-fold increase in the level of phosphorylated S6 protein in
DRGs cell bodies from the ligated nerve compared with those from the contralateral
unligated nerve (Figure 2A, 2B). By four days following ligation, S6 phosphorylation
levels returned to basal, revealing the transient nature of the mTOR pathway activation
(Figure 2B). To confirm that mTOR activation is the source of S6 phosphorylation
following injury, we tested whether S6 phosphorylation in DRG cell bodies upon sciatic
nerve ligation can be blocked by rapamycin, a potent inhibitor of mTOR. DRG cell
bodies of mice injected intraperitoneally with rapamycin prior to sciatic nerve ligation
showed a lower level of S6 phosphorylation compared to those of vehicle-treated ligated
mice, suggesting that mTOR activity contributes to S6 phosphorylation after injury
(Figure 2C, 2D). Interestingly, a minor component of S6 phosphorylation following
injury was resistant to rapamycin, suggesting that in addition to mTOR activity, there
may be mTOR-independent modes of S6 phosphorylation after injury (Figure 2D).
In addition to the increase in S6 phosphorylation levels, we also observed an
increase in the total level of S6 protein itself in DRG cell bodies one day following sciatic
nerve injury (Figure 2A, 2C, 2E). Inhibition of mTOR activity by rapamycin blocked the
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increase in the total level of S6 protein after injury, suggesting that the mTOR pathway
may regulate the translation of S6 itself (Figure 2E).
mTOR contributes to enhance axonal growth capacity following injuryInactivation of the mTOR pathway following injury was shown to mediate the decreased
growth capacity of retinal ganglion cells [25]. To determine whether increased mTOR
activity after injury contributes to the enhanced axonal growth capacity of DRGs, we
used the conditioning injury paradigm, in which prior injury causes a transition in
neuronal morphology (or ‘growth pattern’) from compact, branched arbors to elongated,
more sparsely branched axons [10]. We tested whether the presence of rapamycin, a
potent inhibitor of mTOR activity during the conditioning injury blocks the increase in
axonal outgrowth. To measure the extent of axon outgrowth, we calculated the distance
between the cell body and the tip of the longest axon (‘radial projection length’). DRGs
cultured in the presence of NGF from mice injected intraperitoneally with vehicle as a
control showed the expected ~2 fold increase in mean radial projection length upon a
conditioning injury (Figure 3A, 3B). In contrast, intraperitoneal injection of rapamycin
partially blocked the enhanced radial projection of axons upon a conditioning injury
(Figure 3A, 3B, 3C). These results suggest that the mTOR pathway contributes at least in
part to increase axonal growth capacity following injury.
Deletion of TSC2 in DRGs leads to elevated mTOR activity- To test whether
mTOR activation is sufficient to increase axonal growth capacity, we genetically
increased basal level of mTOR activity by deleting TSC2, a negative regulator of mTOR
activity, in DRGs. Tsc2flox/flox mice [26] were crossed to mice expressing cre under the
control of the advillin promoter, which is expressed almost exclusively in peripheral
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sensory neurons [27]. Tsc2flox/flox; AdvillinCre/+ mice are thereafter referred to as TSC2KO.
Tsc2flox/flox; Advillin+/+ littermates are referred to as control. Deletion of TSC2 was
confirmed by analyzing protein expression in DRGs cell bodies and brain extracts by
western blot (Figure 4A). As TSC2 is a negative regulator of mTOR activity, we
predicted that TSC2 deletion would upregulate mTOR activity. As expected, deletion of
TSC2 in DRGs led to enhanced basal level of S6 phosphorylation, specifically in DRGs
(Figure 4A and 4B). We measured a ~2 fold increase in basal S6 phosphorylation levels
in DRGs cell bodies isolated from TSC2KO mice compared to control littermates, a level
similar to the increase in S6 phosphorylation levels we observed in DRGs cell bodies one
day after injury in wild-type mice (Figure 4B).
DRGs lacking TSC2 display enhanced axonal outgrowth in vitro and in vivoTo test whether increased mTOR activity is sufficient to increase axonal growth capacity
in DRGs in the absence of a conditioning injury, we cultured DRGs from TSC2KO and
control mice in the presence of NGF and assessed axonal outgrowth. TSC2KO DRGs
grew more elongated, less arborized axons compared to those of control DRGs,
mimicking the morphology of DRGs subjected to a conditioning injury (Figure 4C, 4D,
4E). The radial projection length of TSC2KO DRG axon was greater than that of control
littermate and similar to that of control littermate DRGs subjected to a conditioning
injury (Figure 4C, 4D). Conditioning injury to TSC2KO neurons did not significantly
increase radial projection length compared to the uninjured condition, suggesting that
even without the presence of a conditioning injury, TSC2KO DRGs have reached their
maximal growth capacity in this assay (Figure 4C, 4D). The presence of the cre
recombinase is not sufficient to enhance axonal growth capacity, as wild-type;
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AdvillinCre/+ mice did not show significant difference with wild-type; Advillin+/+
littermate controls (Figure 4F).
To test whether TSC2 deletion facilitates axonal regeneration in vivo, we crushed
the sciatic nerve in TSC2KO mice and control littermates and assessed the level of
regeneration past the crush site 12 or 24 hours later. To visualize re-growth of damaged
axons, longitudinal sciatic nerve sections were stained for the growth-associated protein
GAP-43. The reported concentration of GAP-43 in axonal growth cone [28]together with
its strong expression in regenerating axons [29] makes it an ideal marker to track nerve
regeneration in vivo [30]. The length of GAP-43-expressing axons past the crush site was
markedly increased in TSC2KO sciatic nerve compared to that of control littermates
(Figure 5A, 5B). We quantified this increase by normalizing GAP-43 fluorescence
intensity to that at the crush site to control for the increased GAP-43 expression level
observed from TSC2KO neurons (Figure 6B, 6C). We calculated a regeneration index by
measuring the distance away from the crush site in which the average GAP-43 intensity is
half that observed at the crush site. The regeneration index was significantly higher in
TSC2KO sciatic nerves compared to control nerves for both the 12 and 24 hours
timepoints (Figure 5C). Thus, this result suggests that enhanced mTOR activity is
sufficient to facilitate axon regeneration in vivo.
mTOR activity regulates GAP-43 expression following injury- GAP-43 is a
crucial component of axonal outgrowth in developing and regenerating neurons
[29,31,32]. The enhanced growth capacity of neurons lacking TSC2 may thus result from
an enhanced expression of GAP-43. To directly test whether mTOR activity regulates
GAP-43 expression following injury, we analyzed GAP-43 levels in nerve portions
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proximal and distal to an axotomy site and in contralateral non-injured sciatic nerve by
western blot. 24 hours after injury, GAP-43 protein level increased in the sciatic nerve
proximal to the injury site in both TSC2KO and control and mice (Figure. 6B, 6C).
Accumulation of GAP-43 in the proximal nerve stump is consistent with its role in
promoting axonal outgrowth. However, both the basal and injury-induced levels of GAP43 in the sciatic nerve were significantly higher in TSC2KO mice compared to controls
(Figure 6B, 6C). Cultured DRGs also show a higher GAP-43 expression at the cell body
and the tip of growing axons (Figure 6A). In contrast to the local increase of GAP-43
expression in sciatic nerve, injury did not increase GAP-43 levels in the DRGs cell
bodies of TSC2KO mice or controls. However, the basal level of GAP-43 expression was
enhanced in TSC2KO DRGs as observed in the sciatic nerve (Figure 6D, 6E).
To confirm that mTOR activity is required for the increase in GAP-43 expression
after injury, we tested whether inhibition of mTOR by rapamycin reduces GAP-43
protein levels in injured and uninjured sciatic nerve. Intraperitoneal injection of
rapamycin one hour prior to injury partially blocked the increase in GAP-43 expression
in the proximal injured nerve stump (Figure 6F, 6G). Together, these results suggest that
mTOR activity regulates GAP-43 expression in peripheral nerves following injury.
To determine whether the effect of TSC2 deletion on GAP-43 expression is
specific to GAP-43 or is due to a global upregulation of protein translation, we
determined whether the levels of other proteins are also increased in TSC2 KO DRGs.
We examined the levels of peripherin and β−actin, whose translation after injury has been
implicated in axon regeneration [16,33]. The basal level of peripherin and β−actin in
uninjured sciatic nerve were not significantly different between control and TSC2 KO
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mice (Figure 7A, 7B). Furthermore, the elevated level of these proteins in injured sciatic
nerve were also unaffected by TSC2 deletion (Figure 7C, 7D). The expression levels of
these proteins were also not significantly altered in DRGs cell bodies of TSC2 KO mice
compared to control (Figure 7C, 7D). Thus, mTOR may be regulating the expression
level of a specific subset of proteins that includes GAP-43.
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DISCUSSION
The extent of axonal regeneration not only depends on the presence or absence of
inhibitory cues in the environment, but also on the intrinsic growth capacity of the
damaged neurons. Research on nerve regeneration has largely focused on identifying the
inhibitory molecules in the CNS environment that act as barriers to regeneration. Recent
evidence suggests that in addition to differences in their environments, CNS and PNS
neurons differ in their intrinsic ability to regrow their axons after injury.
Work in retinal ganglion cells has implicated the mTOR pathway in regulating the
growth capacity of neurons. Axotomy to retinal ganglion cells markedly reduces mTOR
activity while genetic activation of mTOR activity by PTEN or TSC1 deletion is
sufficient to boost the regenerative ability in these normally non-regenerating neurons
[25]. We found that in contrast to retinal ganglion cells, DRG neurons in the PNS activate
the mTOR pathway in response to injury. Activation of the mTOR pathway in DRGs
implies that the ability of PNS neurons to regenerate is not solely due to the lack of
inhibitory molecules in the environment, but also to an active intracellular mechanism
that enhances growth capacity. Indeed, we find that rapamycin blocks the enhancement
in axonal outgrowth following a conditioning injury, suggesting that mTOR activity
contributes to boost the regenerative potential after damage. The observation that mTOR
activation is transient and returns to basal level 3 to 4 days following injury suggests that
prolonged mTOR activity may further enhance PNS regeneration.
Similarly to what was observed in CNS neurons, we found that upregulation of
the mTOR pathway is sufficient to enhance axonal growth capacity in PNS neurons.
Genetic ablation of TSC2, a negative regulator of mTOR activity, led to enhanced axonal
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outgrowth and regenerative capacity in DRGs. TSC2KO DRGs grew faster, more
elongated and sparsely branched axons in culture, similarly to wild-type DRGs subjected
to a conditioning injury [10]. Thus, increased mTOR activity is sufficient to enhance
axonal growth potential even in the absence of a conditioning injury. We also observed
that injured TSC2KO DRGs grew further past the injury site in vivo compared to control
DRGs. Based on our observation that TSC2 deletion primes DRGs to grow long axons in
vitro in the absence of a conditioning injury, TSC2KO DRGs may also be primed to
respond to injury in vivo and initiate axon regrowth earlier than control DRGs.
Alternatively, TSC2 deletion may affect injury-induced retraction that occurs prior to
axon elongation. Clearly, a more detailed analysis will determine the precise mechanism
regulating regenerative growth in the absence of TSC2. Nevertheless, the observation
that TSC2 deletion can facilitate the regrowth of crushed peripheral axons in vivo
supports the notion that regeneration of injured axons in the PNS can be further enhanced.
The major downstream targets of mTOR are components of the translation
machinery, including those that regulate the recruitment of ribosomes to mRNA. Protein
synthesis plays a critical role in both injury signaling [16,34,35,36] and the formation of
new growth cones during regeneration [37]. Several proteins translated in peripheral
neurons after injury, including vimentin and importin β, have been shown to be critical
for regeneration [16]. However, whether their expression is regulated by mTOR activity
has not been explored. Our present study identified GAP-43 as a downstream target of
mTOR activity. TSC2KO neurons showed enhanced GAP-43 levels both in naïve and
injury-induced conditions. In addition, rapamycin treatment partially blocked the
increase in GAP-43 protein levels after injury, showing that the mTOR pathway regulates
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GAP-43 expression. As GAP-43 plays a key role in axon sprouting and outgrowth in
regenerating axons [31,32] [38], [39], it is likely that the enhancement of axon growth
capacity by the mTOR pathway is at least in part due to the regulation of GAP-43
expression. However, overexpression of GAP-43 alone is not sufficient to fully stimulate
regrowth of axons in the central branch of DRGs into the spinal cord [11]. Thus, the
mTOR pathway likely regulates the translation of a number of proteins in addition to
GAP-43 to maximize the axonal growth capacity.
Our work indicates that PNS neurons turn on the mTOR pathway following injury,
while CNS neurons do not [25]. It will therefore be important in future studies to identify
the upstream regulators of mTOR that are specifically activated by PNS injury to better
understand the poor regenerative ability of CNS neurons. In non-neuronal cells, a number
of upstream regulators of mTOR have been identified, and include the serine/threonine
protein kinase Akt and the TSC1-TSC2 complex. Growth factors, nutrients and insulin
among other factors activate PI-3Kinase, which leads to the phosphorylation and
activation of Akt. Active Akt in turn phosphorylates and inhibits TSC2 activity leading to
mTOR activation via Rheb GTPase [40,41,42,43,44] (Figure 1). Surprisingly, we did not
detect Akt phosphorylation in DRGs cell bodies 24 hr after injury at time points at which
S6 is already phosphorylated (Figure 8A). A recent study reported a decrease, rather than
an increase in Akt phosphorylation levels in DRGs three days following sciatic nerve
injury [45]. However, as chronic activation of mTOR can downregulate Akt activation
via a feedback mechanism, a more detailed time-course study of Akt activation should be
performed to address whether mTOR activation after injury occurs through Akt [46].
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Interestingly, we found that TSC2KO DRGs, which have an increased basal level
of S6 phosphorylation, are able to further increase S6 phosphorylation levels upon sciatic
nerve injury even in the absence of TSC2 (Figure 8B). Thus, inactivation of TSC2 by Akt
may not fully account for mTOR activation in DRGs cell bodies after injury, and other
pathways independent of TSC2 may converge to activate mTOR. One TSC2independent mode of mTOR regulation occurs through phosphatidic acid [47] (Figure
8C). Phosphatidic acid production is mediated by phospholipase D1, which is activated
by the small GTPase Cdc42 [48]. Interestingly, Cdc42 mRNA is upregulated in DRGs
following axotomy, and Cdc42 overexpression induces enhanced axonal outgrowth [49].
Another possible TSC2-independent regulator of mTOR activity is the JAK-STAT–
SOCS3 signaling pathway (Figure 8D). SOCS3 is a negative regulator of JAK-STAT
signaling which suppresses regeneration in retinal ganglion cells [50]. Genetic deletion of
SOCS3 in retinal ganglion cells is sufficient to activate the mTOR pathway and promotes
regeneration [50]. In DRGs, injury induces activation of JAK-STAT signaling through
the cytokine CNTF and its receptor gp130 [51], suggesting that CNTF-mediated JAKSTAT signaling may interact with the mTOR pathway after peripheral nerve injury.
Enhancement of axonal regeneration in both CNS and PNS neurons by activation
of the mTOR pathway presents an exciting therapeutic target for facilitating recovery
from nerve injury. However, it remains unclear whether upregulation of mTOR activity
can promote successful target re-innervation in addition to facilitation of axonal regrowth.
Interestingly, we observe that activation of mTOR in injured DRGs is transient, returning
to basal levels after four days following injury (Figure 2A, 2B). This finding led us to
question whether prolonged activation of mTOR in peripheral neurons could have
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deleterious effects on target innervation and functional recovery. In Chapter 4, we
examine the consequences of persistent mTOR activity in peripheral nerve development
and function to speculate whether upregulation of mTOR activity can offer a safe
therapeutic approach to repair injured peripheral neurons.

44

MATERIALS AND METHODS
Antibodies and reagents- The following antibodies were used: anti-tuberin/TSC2 (Santa
Cruz Biotechnology, C-Term), anti-phosphorylated S6 ribosomal protein (Cell Signaling,
Serine 240/244), anti-S6 ribosomal (Cell Signaling), anti- α−tubulin (Sigma), anti-SMI31(Sternberger Monoclonals Incorporated), anti-beta actin (Sigma), anti-peripherin
(Millipore), anti-GAP-43 (Abcam), anti-tau (Synaptic Systems), and anti-GAP-43
(Chemicon) when used with anti-tau.
Animals- For experiments involving wild-type animals, C57B6 6 to 9 month of age
females from Harlan were used. Tsc2flox/flox animals were previously described [26]and
AdvillinCre/Cre mice were used to drive expression of cre in sensory neurons, based on the
previous characterization of the advillin-hPLAP reporter mouse [27,52]. To generate
Tsc2flox/flox; AdvillinCre/+ conditional knockout mice, we crossed Tsc2flox/flox females to
AdvillinCre/Cre males to generate Tsc2flox/+; AdvillinCre/+ animals. Then,
Tsc2flox/floxAdvillin+/+ females were crossed to Tsc2flox/+; AdvillinCre/+ males to generate
Tsc2flox/flox; AdvillinCre/+ conditional knockout animals and Tsc2flox/flox; Advillin+/+
littermate control animals. Genotype was confirmed by tail PCR at weaning age. 4-8
weeks old animals and sex- matched littermate controls were used for all experiments.
Surgical procedures and drug treatment- All surgical procedures were approved by the
Washington University in St. Louis, School of Medicine, Animal Studies Committee.
Sciatic nerve injury experiments were performed as described previously ([12]). Briefly,
the right sciatic nerves of mice were ligated, axotomized, or crushed unilaterally at the
midpoint, and mice were sacrificed at the indicated time after surgery. For biochemistry
on DRGs cell bodies, L4, L5, and L6 DRGs were dissected from both the injured side

45

and the contralateral uninjured side for control. For biochemistry on sciatic nerve, equal
lengths (5mm) of the proximal and distal parts were homogenized. DRGs and nerves
were homogenized in lysis buffer (20mM Tris-HCl pH 7.5, 150mM NaCl, 1mM
Na2EDTA, 1mM EGTA, 1% Triton, 2.5mM sodium pyrophosphate, 1mM βglycerophosphate, 1mM Na3VO4, 1μg/ml leupeptin) with phosphatase inhibitor cocktail 1
and 2 (Invitrogen). Equal protein amounts were loaded and analyzed by SDS-PAGE and
western blot.
Rapamycin was delivered by intraperitoneal injection at 5mg/kg body weight.
Rapamycin was dissolved in 200 μl DMEM from a 10 mg/ml stock solution in DMSO.
An equivalent volume of DMSO was dissolved into 200 μl DMEM for vehicle control.
Intraperitoneal injection was performed 1 hr before sciatic nerve ligation, and repeated
two days following ligation. Animals were sacrificed and DRGs and nerves were
dissected one or four days following ligation.
Primary DRGs culture and immunofluorescence- L4, L5, and L6 DRGs were dissected
and dissociated in 0.7 mg/ml Liberase Blendzyme 3 (Roche), 600 µg/ml DNAse, 10
mg/ml BSA, in DMEM AIR (DMEM/F12 with 10mM Glucose, and 1% Pen/Strep) at
37ºC for 15 minutes, followed by trypsinization with 0.25% trypsin in DMEM AIR at
37°C for 15 minutes. DRGs were then triturated and placed in culture media (DMEM,
10% FBS, 1% pen/strep) with 50ng/ml NGF (Invitrogen) on poly-D-lysine-coated plates.
After 20-24 hrs, DRGs were fixed in 4% paraformaldehyde and 4% sucrose in
PBS for 10 minutes. For immunofluorescence staining, cells were permeabilized and
blocked in 10% Goat Serum, 0.1% Triton-X in PBS for 15 minutes. Staining was
performed with the indicated primary antibodies for 30 minutes at room temperature, and
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with Alexa-conjugated secondary antibodies for 20 minutes. Images were acquired with
Nikon Eclipse TE2000-E inverted microscope and analyzed using Nikon NIS Elements
Advanced Research 2.30 Imaging Software. To quantify levels of axonal outgrowth, we
measured the distance between the cell body and the tip of the longest axon and
annotated this measurement as the radial projection length. For each condition, radial
projection lengths of all cells imaged were measured, and both means and histograms
were used for comparison across conditions.
Immunohistochemistry- Crushed sciatic nerves were dissected and fixed for 1-2 hours in
4% PFA in PBS, then cryoprotected overnight in 20% sucrose. Posterior hindpaw skin
sections were fixed in 15% picric acid, 2% paraformaldehyde in PBS for 3-4 hours, and
cryoprotected in 30% sucrose for 48 hours. Nerves and skin were embedded in OCT
(Tissue-Tek) and frozen in dry-ice-cooled methanol. Serial 10-µm (nerve) or 30-µm
(skin) cryostat sections were cut and mounted onto coated slides (Fisher Scientific).
Sections were permeabilized and blocked with 10% goat serum, 0.1% Triton X-100 in
PBS for 30 min. Primary staining with the indicated antibodies was performed in the
blocking solution overnight at 4ºC. Staining with Alexa-conjugated secondary antibody
was performed for 1 to 3 hours. Sciatic nerve images were acquired with Nikon Eclipse
TE2000-E inverted epifluorescence microscope and analyzed using Metamorph 6.2.
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Figure 1. Major components of the mTOR pathway
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Figure 2. The mTOR pathway is upregulated in DRG cell bodies following sciatic
nerve injury
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Figure 2. The mTOR pathway is upregulated in DRG cell bodies following sciatic
nerve injury (A) Injury to the sciatic nerve of wild-type mice was induced by ligation
and S6 phosphorylation levels were assessed in L4, L5, L6 DRG cell bodies at the
indicated time points. DRG cell bodies display increased S6 phosphorylation levels one
to two days following ligation. L4, L5, L6 DRG lysates from one mouse were pooled for
each time point. Cytochrome c was used as loading control. (B) Quantification of fold
change in S6 phosphorylation levels between DRG cell bodies from injured and uninjured nerves shows 2 fold increase in S6 phosphorylation one day after ligation which
reached basal level 4 days following ligation. S6 phosphorylation levels were normalized
to loading control. At least 4 mice were tested for each time point. Data are mean +/SEM. *p<0.05 (Student’s t-test). (C) Wild-type mice were treated with rapamycin or
DMSO as a vehicle control by intraperitoneal injection and then subjected to sciatic nerve
ligation to provoke injury one hour later. L4, L5 and L6 DRGs were dissected 24 hours
later and S6 phosphorylation levels were assessed by western blot. L4, L5, L6 DRG
lysates from one mouse were pooled for each time point. Basal and injury-induced levels
of S6 phosphorylation are significantly reduced by rapamycin treatment. Tubulin was
used as loading control. (D) Quantification of S6 phosphorylation levels from (A) shows
a major component of S6 phosphorylation after injury is mTOR-dependent. S6
phosphorylation levels were normalized to loading control. 4 mice were tested for each
condition. Data are mean +/- SEM. *p<0.05, ***p<0.001 (Student’s t-test). (E)
Quantification of total S6 protein levels of DRGs from (A) shows increase in total S6
levels following injury is mTOR-dependent. Total S6 levels were normalized to loading
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control. 4 mice were tested for each condition. Data are mean +/- SEM.
*p<0.05(Student’s t-test).
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Figure 3. The mTOR pathway contributes to enhance axonal growth capacity after
peripheral nerve injury
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Figure 3. The mTOR pathway contributes to enhance axonal growth capacity after
peripheral nerve injury. (A) Wild-type mice were treated with rapamycin or DMSO as
a vehicle control by intraperitoneal injection and then subjected to sciatic nerve ligation
to provoke injury one hour later. L4, L5 and L6 DRGs were dissected and cultured 4
days later. DRG cultured from injured sciatic nerve showed enhanced axonal outgrowth
at 24 hours in culture. This effect was partially blocked by rapamycin. Axons were
stained with α-SMI-31 antibody. (B) Quantification of radial projection length of naïve
and injury-conditioned DRGs cultured from vehicle or rapamycin treated mice show
rapamycin partially blocks conditioning injury paradigm. n=4 mice per condition; 100350 neurons were analyzed per set of DRGs. Data are mean +/-SEM. *p<0.05, **p<0.01,
***p<0.001 (Student’s t-test). (C) Histogram of radial projection length of injuryconditioned DRGs from one representative experiment shows shift in distribution upon
rapamycin-treatment. (A) Bar=100μm.
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Figure 4. TSC2KO DRGs display enhanced axonal outgrowth in vitro.
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Figure 4. TSC2KO DRGs display enhanced axonal outgrowth in vitro. (A) Western
blot of DRG cell bodies and brain lysates from TSC2KO and control animals show that
TSC2 protein level are dramatically reduced in DRGs but not in brain. As expected, S6
phosphorylation level is increased in TSC2KO compared to control animals.
Representative western blot is shown (B) Quantification of (A); n=5 mice per genotype,
Data are mean +/- SEM. **p<0.01(Student’s t-test). (C). Cultured TSC2KO DRGs show
enhanced axonal outgrowth in the absence of a conditioning injury. Injury to the sciatic
nerve 4 days prior to dissociation does not further increase axonal outgrowth in TSC2KO
DRGs. Axons were stained with α-SMI-31 antibody. (D) Quantification of radial
projection of naïve and injury-conditioned DRGs cultured from TSC2KO mice and
controls. n=3 mice per genotype; 60-370 neurons were analyzed per set of DRGs. Data
are mean +/- SEM. n.d.=no statistically significant difference, *p<0.05, **p<0.01
(Student’s t-test). (E) Histogram of radial projection lengths of naive TSC2KO and
control DRGs in culture. Data shown is from one representative experiment. (F) There
was no significant difference in radial projection length between DRGs cultured from
wild-type; AdvillinCre/+ mice and those cultured from wild-type; Advillin+/+ mice. n=3
mice per genotype. 100 to 200 neurons were measured per genotype. Data are mean +/SEM. n.d.=no statistically significant difference (Student’s t-test). (C) Bar=100μm.
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Figure 5. TSC2KO neurons display enhanced regeneration in vivo.
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Figure 5. TSC2KO neurons display enhanced regeneration in vivo. TSC2KO and
control mice were subject to a sciatic nerve crush, and regeneration of crushed axons was
assessed 12 or 24 hours later. (A) Longitudinal section of sciatic nerve dissected 12 or 24
hours after crush reveals increased length of GAP-43 positive axons past the crush site in
TSC2KO mice compared to control mice for both time points. Dashed line indicates
crush site. (B) Average GAP-43 intensity at various distances distal to crush site 12 and
24 hours after crush reveal regenerating axons grew longer distances in TSC2KO mice
compared to controls. GAP-43 intensity values were normalized to that at the crush site
to control for the increased GAP-43 expression level observed from TSC2KO neurons.
Data are mean +/- SEM. n=3 mice per genotype, 3 to 5 longitudinal sections were
analyzed per mouse for both time points (Student’s t-test). (C) Regeneration index was
measured as the distance away from the crush site in which the average GAP-43 intensity
is half that observed at the crush site. TSC2KO mice show a higher regeneration index
compared to controls at both 12 and 24 hour timepoints.. *p<0.05, **p<0.01 (Student’s
t-test). (A) Bar=200μm.

58

Figure 6. The mTOR pathway regulates GAP-43 expression.
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Figure 6. The mTOR pathway regulates GAP-43 expression. (A) Naïve TSC2KO
DRGs show enhanced cell body and axonal GAP-43 expression in culture. Arrows
indicate cell body, arrowheads indicate axonal tips. (B) Injury to the sciatic nerve of
TSC2KO and control mice was induced by axotomy and GAP-43 levels in nerve portions
proximal and distal to the axotomy site and in contralateral non-injured sciatic nerve were
analyzed by western blot 24 hours later. Control mice show an increase in GAP-43
expression in sciatic nerve proximal to the injury site. Both the basal level and injuryinduced level of GAP-43 expression is enhanced in TSC2KO mice. GAP-43 levels were
normalized to loading control (tubulin). Data are mean +/- SEM. n=3 mice per genotype,
*p<0.05 (Student’s t-test). (C) Representative western blot from one experiment (one
mouse per genotype) from (B). (D) As in (B), but DRG cell bodies were analyzed.
GAP-43 levels were increased in DRG cell bodies of TSC2KO mice compared to control.
Axotomy did not increase GAP-43 levels in DRG cell bodies in either genotype. n=3
mice per genotype, **p<0.01 (Student’s t-test). (E) Representative western blot from one
experiment (one mouse per genotype) from (C). (F) Rapamycin blocks increase in GAP43 expression after injury. Wild-type mice were injected intraperitonealy with rapamycin
or DMSO vehicle control, then sciatic nerve injury was induced by ligation. Four days
following ligation, unligated nerve and ligated nerve distal and proximal to the ligation
site were analyzed for GAP-43 expression. Data are mean +/- SEM. n=3 mice per
condition. *p<0.05, *p<0.01 (Student’s t-test). (G) Representative western blot from one
experiment from (F). (C) Bar=100μm.

60

Figure 7. TSC2 deletion in DRG does not affect peripherin or β-actin expression.
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Figure 7. TSC2 deletion in DRG does not affect peripherin or β-actin expression.
(A) Injury to the sciatic nerve of TSC2KO and control mice was induced by axotomy.
peripherin and β-actin levels in nerve portions proximal and distal to the axotomy site
and in contralateral non-injured sciatic nerve were analyzed by western blot 24 hours
later. No significant difference in basal or injury-induced levels of peripherin or β-actin
between TSC2KO and control mice was observed. Peripherin and β-actin levels were
normalized to loading control (tubulin). Data are mean +/- SEM. n=3 mice per genotype.
n.d.=no statistically significant difference (Student’s t-test). (B) Representative western
blot from one experiment (one mouse per genotype) from (A). (C) As in (A), but DRG
cell bodies were analyzed. Peripherin and β-actin levels in DRG were not significantly
different between TSC2KO and control. Data are mean +/- SEM. n=3 mice per genotype.
n.d.=no statistically significant difference (Student’s t-test). (D) Representative western
blot from one experiment (one mouse per genotype) from (C).
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Figure 8. mTOR activation after peripheral nerve injury may be Akt/TSC2independent.
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Figure 8. mTOR activation after peripheral nerve injury may be Akt/TSC2independent.
(A) Injury to the sciatic nerve of wild-type mice was induced by ligation and
phosphorylation of Akt (S473) and S6 was assessed in L4, L5, L6 DRG cell bodies at the
indicated time points. While S6 phosphorylation was observed at 12 and 24 hour time
points, Akt phosphorylation was not detected. Cytochrome c was used as loading
control. (B) TSC2 KO DRGs cell bodies further upregulate S6 phosphorylation after
sciatic nerve axotomy. DRGs were collected 24 hours after sciatic nerve axotomy and
analyzed by western blot with the indicated antibodies. Tubulin was used as loading
control. (C) Potential Akt/TSC2-independent modes of mTOR activation.
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Chapter 3: Persistent mTOR activity in peripheral neurons leads to developmental
and functional defects

Part of this work appears in the manuscript:
Abe N, Borson SH, Gambello MJ, Wang F, Cavalli V (2010) mTOR activation increases
axonal growth capacity of injured peripheral nerves. J Biol Chem. In press.

Contributions: Experiments in figure 4 were performed by Judy Golden.
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ABSTRACT
Enhancement of axonal regeneration in both CNS and PNS neurons by activation
of the mTOR pathway presents an exciting therapeutic target for facilitating recovery
from nerve injury. However, it remains unclear whether upregulation of mTOR activity
can promote successful target re-innervation and functional recovery in addition to
axonal regrowth. Here, we examined the consequence of prolonged mTOR activity by
conditional deletion of TSC2 in dorsal root ganglia (DRGs). Deletion of TSC2 in DRGs
in vivo resulted in major developmental and functional defects, including increased
mortality, small size, early death, sensory impairments, movement abnormalities, and
aberrant target innervation and axon morphology. These developmental and functional
defects suggest that prolonged elevation of mTOR activity may also interfere with axon
targeting and functional recovery of regenerating axons. Thus, while manipulation of the
mTOR activity could provide new strategies to stimulate nerve regeneration in the PNS,
fine control of mTOR activity may be required for proper target innervation and
functional recovery.
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INTRODUCTION
While much research in nerve regeneration has focused on identifying extrinsic or
intrinsic factors that accelerate growth, little is known regarding the consequences of
prolonged potentiation of growth pathways on target re-innervation and functional
recovery. As neurotrophin-mediated growth pathways are intimately linked to axon
guidance [1,2], it is possible that over-activation of axon growth could interfere with
axon navigation and target innervation. Genetic activation of the mTOR pathway in PNS
and CNS neurons facilitates axon regrowth, raising the exciting possibility that this
pathway may be targeted for therapy following nerve injury [3,4]. However, whether
persistent activation of mTOR in peripheral neurons has deleterious effects on target
innervation or function has not yet been explored. Given the growing evidence for the
role of mTOR in multiple aspects of neuronal development, it is possible that
hyperactivation of mTOR activity in peripheral neurons could disrupt axon targeting and
function.
Persistent mTOR activity in the central nervous system contributes to many of the
pathologies of Tuberous Sclerosis (TSC) [5,6]. TSC is an autosomal dominant disorder
associated with hamartoma formation resulting from inactivating mutations in either
TSC1 or its interacting gene TSC2 [7,8]. TSC2 is a GTPase-activating protein for RhebGTPase, which is an activator of mTOR [9]. TSC1 does not have any known functional
domains but binds to and prevents the degradation of TSC2 [10]. While TSC can affect
multiple organs including skin, kidney, heart, lung, and eye, the most significant patient
morbidity is attributed to its effects on the brain [11]. Common neurological symptoms
of TSC patients include epilepsy, autism, and cognitive disabilities and are associated
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with developmental malformations of the cerebral cortex called cortical tubers [12,13,14].
Cortical tubers consist of giant cells, which are large ovoid cells unique to TSC patients
and extend short, thickened process of unclear identity [15]. Consistent with a role of the
TSC1-TSC2 complex in inhibiting mTOR activity, giant cells display an elevated level of
S6 phosphorylation indicative of hyperactive mTOR signaling [15,16]. Neuron-specific
deletion of TSC1 in mice results in many of the features and pathologies of tuberous
sclerosis, including spontaneous seizure activity, the presence of enlarged, aberrant
neurons characteristic of those in TSC cortical tubers, and hyperactive mTOR signaling
[5].

Rapamycin, an mTOR inhibitor, can reverse many of these abnormalities in this

TSC mouse model, indicating that hyperactive mTOR signaling contributes to TSC
pathologies [6].
The TSC1 and TSC2 tuberous sclerosis complex plays a critical role in axon
specification of hippocampal neurons through its regulation of mTOR activity [17].
Specification of neuronal processes as axon or dendrite is essential for proper neuronal
function and information flow. In vitro studies of hippocampal neurons show that TSC2
phosphorylation, and downstream mTOR signaling is restricted to the axon [17].
Deletion of TSC1 or TSC2 results in the formation of multiple axons, suggesting that
spatial regulation of mTOR activity essential for axon specification and neuronal polarity
[17]. Rapamycin treatment reduces the number of TSC1 or TSC2-deficient neurons with
multiple axons, suggesting that the TSC1-TSC2 complex regulates axon specification
through its modulation of mTOR activity [17].
Recent studies in retinal ganglion neurons have identified a role of TSC1-TSC2
and mTOR in axon guidance [18]. TSC2 heterozygote mice show aberrant projections of
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retinal ganglion neurons into the dorsal lateral geniculate nucleus (dLGN) [18]. TSC2
deficient neurons in culture are insensitive to ephrin-mediated growth cone collapse,
suggesting that TSC2 acts downstream of ephrin signaling which is critical for the
formation of the topographic map in the dLGN [18]. Furthermore, ephrin-mediated
growth cone collapse involves inhibition of protein translation by TSC2-mediated mTOR
inactivation [18]. Thus, fine modulation of mTOR activity by axon guidance cues may
play an instructive role in axonal targeting.
In chapter 2, we report that genetic upregulation of mTOR activity in dorsal root
ganglia (DRG) facilitates axonal regrowth following injury. Given the therapeutic
potential of mTOR activation in nerve injury, it is important to test the consequence of
persistent mTOR activity on target innervation and function. Here, we extend the work
described in chapter 2 by further characterization of the phenotype of TSC2flox/flox;
AdvillinCre/+ conditional knockout mice (TSC2KO), in which deletion of TSC2 in DRGs
results in hyperactive mTOR signaling (Chapter 2, Figure 4A, 4B). We find that TSC2
deletion in DRGs results in increased mortality, smaller body size, abnormal posture,
ataxia, and early death. Furthermore, TSC2 knockout DRGs display larger soma,
abnormal morphology, altered target innervation, and functional defects. Thus, while
manipulation of the mTOR activity could provide new strategies to stimulate nerve
regeneration in the PNS, fine control of mTOR activity may be required for proper target
innervation and functional recovery.
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RESULTS
TSC2KO mice have increased mortality and are smaller in size- To generate
TSC2flox/flox; AdvillinCre/+ mice, we bred TSC2flox/flox; Advillin+/+ females to TSC2flox/+;
AdvillinCre/+ mice. Because female mice show leaky expression of Cre recombinase in
the germline (personal communication with Fan Wang), we used male mice to pass down
the AdvillinCre knock-in allele. For the male in this breeding scheme, we used TSC2flox/+;
AdvillinCre/+ mice rather than TSC2flox/flox; AdvillinCre/+ mice (TSC2KO) as TSC2KO male
mice were unable to breed. Only 12% of the pups born from this breeding were
TSC2KO, which is about half of the expected Mendelian percentage of 25% (Figure 1A).
The remaining three genotypes were born at equal ratios (Figure 1A). Thus, TSC2
deletion in DRGs may be interfering with development in utero.
Of the TSC2KO mice that are born, many are smaller in size compared to control
siblings (Figure 1B, 1C). Over the first few months following birth, these mice become
progressively ataxic, develop tremors, and die around 2.5 ~ 3 months of age. The cause
of death is not yet determined. TSC2+/+;AdvillinCre/+ mice display a wild-type phenotype,
confirming that these abnormalities are due to deletion of TSC2 rather than the
expression of the Cre recombinase.
TSC2-deficient DRGs have axon targeting defects and abnormal morphologyTo assess whether constitutive mTOR activity in DRGs alters axonal target innervation,
we examined sensory nerve innervation of hindlimb glabrous footpad skin in adult
TSC2KO and control littermates. TSC2 deletion led to a significant loss of epidermal
innervation (Figure. 2A, 2B). We found no gross effects of TSC2 deletion on neuronal
survival or the number of axons in the peripheral branch of L5 DRG (Figure 3A-3C),
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suggesting that the loss of innervation is due to axon targeting defects rather than
degeneration or neuronal loss. Furthermore, of the sensory nerves that innervated the
epidermis, a large proportion displayed excessive branching at the axon terminal (Figure
2A, 2C). Not only was the proportion of endings with excessive branching higher in
TSC2KO mice, the absolute number of these endings was also greater (Figure 2D). The
presence of the cre recombinase does not alter skin innvervation, as wild-type;
AdvillinCre/+ mice did not show significant difference from wild-type; Advillin+/+
littermate controls (Figure 2A-D). These results suggest that TSC2 deletion in peripheral
neurons leads to abnormal target innervation and axonal branching. As dorsal root
ganglion neurons also project into the spinal cord, it is also possible that targeting of
these centrally-projecting axons is also disrupted by TSC2 deletion.
TSC2 deletion and increased mTOR-mediated protein synthesis has been shown
to increase cell size in hippocampal neurons as well as non-neuronal cells. We measured
soma size in dissociated DRG cultures from TSC2KO mice and found that TSC2 deletion
results in larger cell size in DRGs (Figure 2E). Thus, mTOR-mediated regulation of cell
size may be conserved across cell types.
TSC2KO mice have defects in sensory nerve function- To determine whether
TSC2 deletion in DRGs results in impaired function in addition to axonal targeting and
morphological defects, we performed a panel of behavioral tests that measure sensory
nerve function. These experiments were performed by Judy Golden in Rob Gereau's
laboratory. TSC2KO mice display lowered sensitivity to thermal and mechanical stimuli,
suggesting that sensory function is compromised (Figure 4A). The response of TSC2KO
mice to acetone, a cold stimulus, was not statistically altered (Figure 4A).
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We also tracked motor behavior of TSC2KO and control mice in an open-field
test. In the span of one hour measured, TSC2KO mice spent significantly less time
moving, and traveled shorter distances compared to control (Figure 4B). Their
movements also appear abnormal, as they walk in a "waddling" pattern with a hunched
back (Figure 4C). They also display a limb clasping phenotype in response to the tail
suspension test, a sign of impaired sensory-motor circuitry. Furthermore, mutant mice
perform poorly on the rotarod test compared to controls, indicative of impaired motor
coordination (Figure 4D). As the conditional deletion occurs in sensory neurons rather
than motor neurons [19], we speculate that these motor defects in TSC2KO mice are a
result of poor proprioception. In addition to defects in peripheral axons, there could also
be defects in the projection of sensory axons back into the spinal cord for connection with
the local motor circuit or the central nervous system. However, it will be critical to
perform lineage tracing analysis of Cre expression pattern using ROSA gene trap mouse
[20], to ensure that the deletion of TSC2 occurs exclusively in DRG neurons.
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DISCUSSION
Deletion of TSC2 in DRGs in vivo resulted in marked developmental and
functional defects, including increased mortality, small size, early death, sensory
impairments, movement abnormalities, and aberrant axon innervation and morphology.
As precise innervation of axons to their target is critical for the function of the nervous
system, we speculate that axon targeting defects in TSC2KO mice contribute to the
impairment of sensory function. Preliminary experiments show that the conduction
velocity of sensory nerves is normal in TSC2KO mice, supporting the idea that the
functional impairments are linked to innervation and morphological defects (with Bob
Baloh).
In the central nervous system, Ephrins mediate axon guidance in retinal ganglion
neurons by modulation of TSC2 and mTOR activity in growth cones [18]. Our finding
that TSC2 deletion interferes with axonal targeting in DRGs suggest that the mTOR
pathway also plays a role in the guidance of peripheral sensory axons. While we cannot
exclude the possibility that these abnormalities are due to mTOR-independent effectors
of TSC2, it is likely that constitutive activation of mTOR contributes to axon innervation
defects given the importance of protein synthesis and degradation in growth cone
dynamics[21,22,23]. Axonal guidance molecules involved in targeting of sensory axons,
including Netrin-1, NGF, and Semaphorin3A mediate growth cone collapse or extension
through local protein translation [24,25]. It is not yet known whether local protein
translation by these axon guidance cues requires mTOR activity. It will be interesting to
examine whether axon guidance molecules in the central and peripheral nervous systems
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converge upon mTOR activity to regulate the directionality of growth cones during
development.
Unlike c-Jun activation which persists in the DRG cell body until regeneration is
complete, the increase in mTOR activity following peripheral nerve injury is a transient
response, returning to basal levels four days following injury. Because prolonged mTOR
activity results in axon targeting defects, it is tempting to speculate that following the
boost of axonal growth by robust activation of mTOR upon injury, the level of mTOR
activity is reduced to allow the axon to be sensitive to extracellular guidance cues for
proper targeting. If fine modulation of mTOR activity is required for the response of
axons to local guidance cues during development, it is likely that this pathway also plays
an instructive role in target re-innervation following axonal damage.

Thus, while

targeting the mTOR pathway to increase the speed and extent of recovery of both PNS
and CNS neurons may represent an attractive clinical strategy, it will be important to
control the duration and level of mTOR activity to allow for proper re-innervation of
targets and functional recovery.
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MATERIALS AND METHODS
Antibodies and reagents- The following antibodies were used: anti-SMI-31, anti-SMI-32
(Sternberger Monoclonals Incorporated), anti-Caspase-3 (Millipore), and anti-GAP-43
(Abcam). For TUNEL staining, in situ cell death detection kit (Roche) was used
according to product protocol.
DRG dissociation for size analysis- L4, L5, and L6 DRGs were dissected and dissociated
in 0.7 mg/ml Liberase Blendzyme 3 (Roche), 600 µg/ml DNAse, 10 mg/ml BSA, in
DMEM AIR (DMEM/F12 with 10mM Glucose, and 1% Pen/Strep) at 37ºC for 15
minutes, followed by trypsinization with 0.25% trypsin in DMEM AIR at 37°C for 15
minutes. DRGs were then triturated and placed in culture media (DMEM, 10% FBS, 1%
pen/strep) on poly-D-lysine-coated plates. DIC images were acquired with Nikon Eclipse
TE2000-E inverted microscope and analyzed using Nikon NIS Elements Advanced
Research 2.30 Imaging Software.
Immunohistochemistry- Sciatic nerves and L4 DRGs were dissected and fixed for 1-2
hours in 4% PFA in PBS, then cryoprotected overnight in 20% sucrose. Posterior
hindpaw skin sections were fixed in 15% picric acid, 2% paraformaldehyde in PBS for 34 hours, and cryoprotected in 30% sucrose for 48 hours. Nerves and skin were
embedded in OCT (Tissue-Tek) and frozen in dry-ice-cooled methanol. Serial 10-µm
(nerve and DRG) or 30-µm (skin) cryostat sections were cut and mounted onto coated
slides (Fisher Scientific). Sections were permeabilized and blocked with 10% goat serum,
0.1% Triton X-100 in PBS for 30 min. Primary staining with the indicated antibodies
was performed in the blocking solution overnight at 4ºC. Staining with Alexa-conjugated
secondary antibody was performed for 1 to 3 hours. Sciatic nerve images were acquired
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with Nikon Eclipse TE2000-E inverted epifluorescence microscope and analyzed using
Metamorph 6.2. Fluorescent images from hindpaw skin sections were acquired using
Olympus 500 confocal microscope. Confocal images were acquired at 1 µm intervals
and all images from one 30 µm stack were compressed into one image using Metamorph
6.2
Behavioral assays

The Hargreaves, von Frey, acetone withdrawal, open-field, and rotarod tests were
performed by Judy Golden as described previously [26].
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Figure 1. TSC2KO mice have increased mortality and smaller body size

81

Figure 1. TSC2KO mice have increased mortality and smaller body size
(A) Percentage of each genotype born from TSC2flox/flox; Advillin+/+ and TSC2flox/+;
AdvillinCre/+ breeding pair. Fewer TSC2KO pups were born than Mendelian ratio.
(B) TSC2KO mice are smaller in size. Sample TSC2KO and control sibling pair. (C)
Quantification of average weight of each genotype shows TSC2KO mice weigh less than
controls. n=4 mice per age and genotype. *p<0.05 (Student’s t-test).
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Figure 2. TSC2 deletion leads to abnormal target innervation and axon morphology.
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Figure 2. TSC2 deletion leads to abnormal target innervation and axon morphology.
(A) Posterior hindpaw glaborous skin sections were stained with α-GAP-43 to visualize
axonal endings innervating skin. Red dashed line indicate epidermal layer. Low
magnification (15X) confocal images reveal fewer axons penetrating epidermal layer in
TSC2KO mice compared to control. High magnification (60X) confocal images reveal
enrichment of endings with excessive branching (arrow) and sharp turning (arrowhead)
compared to controls. The presence of cre recombinase does not contribute to the
innvervation defects, as wild-type; AdvillinCre/+ mice did not show significant difference
from wild-type; Advillin+/+ littermate or control. (B) Quantification of innervation density
reveals loss of skin innervation in TSC2KO mice. Data are mean +/-SEM. n=3 mice per
genotype, 17-56 sections were analyzed per mouse (Student’s t-test). Quantification of
percentage (C) and number (D) of nerve endings with excessive branching (axons with
more than 2 branches at tip, or those that turned 90 degrees were counted). (E)
Measurement radii of L4, L5 and L6 DRG cell bodies dissociated from TSC2KO or
control mice reveal larger cell size in TSC2KO mice. n=3 animals per genotype, 70-375
cells were analyzed per animal. *p<0.05, n.d.=no statistically significant difference
(Student’s t-test).
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Figure 3. TSC2 deletion does not lead to axon degeneration or apoptosis.
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Figure 3. TSC2 deletion does not lead to axon degeneration or apoptosis. (A) Cross
section of the peripheral branch of L5 DRG stained with the axonal marker SMI-31
revealed no significant difference in axon number between TSC2 KO and controls. (B)
Quantification of (A). n=3 mice per genotype, 2 sections analyzed per mouse (Student’s
t-test). (C) Cross-section of L4 DRGs of 2 month-old adult TSC2KO and control mice
were stained for neuronal cell body marker SMI-32 and the apoptotic markers TUNEL or
Caspase-3. Neither control nor TSC2KO DRGs were positive for TUNEL or Caspase-3.
(A) and (C) Bar=100μm.
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Figure 4. TSC2KO mice have behavioral abnormalities indicative of impaired
sensory function.
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Figure 4. TSC2KO mice have behavioral abnormalities indicative of impaired
sensory function. (A) TSC2KO and control mice were subjected to the Hargraves, von
Frey, and acetone tests for sensitivity to heat, mechanical stimuli, and cold respectively.
Sensitivity to heat and mechanical stimuli are significantly impaired in TSC2KO animals .
Data are mean +/-SEM. **p<0.01 (Student’s t-test). n=6 mice per genotype. (B)
TSC2KO and control mice were subjected to the open field test for one hour, and
monitored for time spent moving and distance traveled to assess motor activity.
TSC2KO animals spent significantly less time moving and traveled fewer distances than
controls. Data are mean +/-SEM. *p<0.05 (Student’s t-test). n=5 mice per genotype.
(C) TSC2KO animals have postural abnormalities. (D) TSC2KO animals show poor
performance on the rotarod test compared to controls. Data are mean +/-SEM. *p<0.05
(Student’s t-test). n=6 mice per genotype.
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Chapter 4: Sunday Driver interacts with two distinct types of axonal vesicles

This work appears as part of the manuscript:
Abe N, Almenar-Queralt A, Lillo C, Shen Z, Lozach J, et al. (2009) Sunday driver
interacts with two distinct classes of axonal organelles. J Biol Chem 284: 34628-34639.
Author contributions: V.C. performed the experiments in Figures 1, 2B, 3A and 3B.
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ABSTRACT
Intracellular trafficking pathways play a critical role in the communication
between the neuronal cell body and distant synaptic terminals for survival, function,
injury signaling, and repair. The motor-binding protein Sunday Driver (syd) has been
previously shown to link vesicular axonal transport to nerve injury signaling. Electron
microscopy and mass-spectrometry analyses of immunopurified syd vesicles have
revealed two classes of syd-associated vesicles of distinct morphology and protein
composition. Gene Ontology analyses of each vesicle protein content have revealed their
unique identity and indicated that one class of syd vesicles belongs to the endocytic
pathway, whereas another may belong to an anterogradely transported vesicle pool. To
validate these findings, we examined the transport and localization of components of syd
vesicles within axons of mouse sciatic nerve. Together, our results lead us to propose that
endocytic syd vesicles function in part to carry injury signals back to the cell body,
whereas anterograde syd vesicles may play a role in axonal outgrowth and guidance.
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INTRODUCTION
The cell body of an injured neuron must receive accurate and timely information
about the site and extent of axonal damage in order to initiate molecular changes,
including the enhancement of intrinsic growth capacity and the initiation of the
regeneration program. The extreme length of axons poses a challenge for such signals to
arrive at the cell body. One mechanism contributing to this process in peripheral neurons
is microtubule-based retrograde transport of locally-activated injury signals. Sciatic
nerve injury experiments in rats and mice have identified several signaling molecules that
are retrogradely transported to the cell body upon injury. For example, mitogen-activated
protein kinases (MAPKs) Erk1 and Erk2 are phosphorylated in sciatic nerve axoplasm
following axonal injury and are targeted for retrograde transport upon binding to
vimentin and the beta-importin/dynein complex [1] [2]. c-Jun N-terminal kinase (JNK) is
also activated in axons upon injury and is retrogradely transported to the cell body [3] [4].
Retrograde transport of JNK leads to JNK and c-Jun activation in the cell body [4].
Activation of JNK and c-Jun in the cell body is essential for the initiation of
transcriptional changes required for axonal regeneration. JNK and c-Jun activation
persists following injury until successful target re-innervation has been achieved [5] [6].
Deletion of JNK2, JNK3, or c-Jun in the nervous system, while causing little effect on
axonal growth during development, leads to a marked defect in regeneration upon injury
[7] [8]. Furthermore, c-Jun activation in DRGs is drastically greater following peripheral
branch axotomy compared to that after central branch axotomy, suggesting that
successful activation of c-Jun contributes to regenerative capacity [9]. The mechanism
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by which activated JNK in peripheral axons is retrogradely transported to the cell body to
initiate c-Jun activation remains unclear.
One candidate regulator of JNK transport following nerve injury is Sunday Driver
(syd). Syd was originally identified in a screen for axonal transport mutants in
Drosophila [10]. Also known as mammalian JNK interacting protein 3 (JIP3) or JSAP1,
syd is part of a family of JNK interacting proteins including JIP1, JIP2, and JIP4 [11]
[12] [13]. In the sciatic nerve, syd and JNK3 form a complex on axonal vesicles and
interact with kinesin-1 for anterograde transport and the dynactin complex for retrograde
transport [3]. Following sciatic nerve injury, JNK is locally activated and activated JNK
and syd are transported mainly retrogradely. Injury induces an enhanced interaction
between syd and dynactin, promoting the retrograde transport of activated JNK and syd
[3]. These observations suggest that syd provides a link between axonal damage signals
and axonal transport. In addition, syd-dependent vesiclar transport may be critical for
axon growth and regeneration as syd deletion in the central nervous system results in
axonal outgrowth defects [14] [15].
To better understand syd function in axonal transport and injury signaling, Valeria
Cavalli and Larry Goldstein developed a purification strategy to isolate syd vesicles from
mouse brain cortices [16]. Electron microscopy analysis of immunoisolated syd vesicles
revealed the presence of two classes of organelles of distinct morphology: large,
endosomal-like vesicles, and smaller-sized vesicles [16] (Figure 1). Immuno-EM
analysis from ligated sciatic nerve revealed that the smaller size syd vesicles move
mainly anterogradely, while the larger size syd vesicles move retrogradely [3].
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In addition, mass spectrometry revealed that the two types of syd vesicles have
distinct molecular compositions. Proteins found in the smaller syd vesicles include
synaptic vesicle proteins (vacuolar ATPase, Rab5, AP50, synaptoporin), traffickingrelated proteins (synaptotagmin VII, SNAP29), signaling proteins (sprouty, Minkk1
kinase, casein kinase), cell adhesion proteins (neogenin, neurocan), cytoskeletal proteins,
and ribosomal proteins [16]. Among the proteins identified in the larger syd vesicles
were molecular motors (dynein, kinesin heavy chain, Myosin Va), trafficking-related
proteins (Rab15, Rab18, RabGDI), endosomal proteins (VAMP3, Syntaxin13, Rab5,
Rab7, Rab11, dynamin, AP180, neurobeachin, AP2, amphiphysin, clathrin), ubiquitinrelated proteins (ubiquitin carboxyl-terminal hydrolase 5, Phr1, Cullin-associated
NEDD8-dissociated protein 1), signaling proteins (adenylate cyclase, phosphoinositide
kinases), transporters, channels, and cytoskeletal proteins. [16].
Electron microscopy images combined with mass-spectrometry analyses of these
two distinct classes of syd vesicles indicate that the large vesicles belong to the endocytic
pathway, while the smaller vesicles belong to an anterogradely transported vesicle pool.
To validate these findings, we examined the transport and localization of components of
these distinct syd vesicle classes within axons of mouse sciatic nerve. Together, our
results lead us to propose that endocytic syd vesicles function in part to carry signals back
to the cell body, whereas anterograde syd vesicles may play a role in axonal outgrowth
and guidance.
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RESULTS
In vivo validation of components of syd vesicles -Previous biochemical analyses
revealed the isolation of two populations of syd vesicles with distinct protein composition
and morphology, and immuno-EM analyses showed that in mouse sciatic nerve,
anterogradely moving syd-associated vesicles are mostly small vesicles/tubules and
retrogradely transported syd vesicles are larger, often multivesicular organelles [3]. Small
syd vesicles may belong to the anterograde pathway, whereas large syd vesicles may
belong mainly to the retrograde pathway. To test this possibility, we used sciatic nerve
ligation experiments to assess in vivo the transport properties of several markers
identified in each type of syd vesicle. Mouse sciatic nerves were subjected to ligations,
and nerve portions proximal or distal to the ligation site were analyzed by
immunofluorescence microscopy and Western blotting. Proteins moving in the fast
anterograde axonal transport pathway generally accumulate on the proximal side of a
ligation, while proteins moving in the retrograde pathways generally accumulate on the
distal side. Slow moving or non-axonal proteins remain unchanged.
Immunofluorescence of longitudinal sections of a ligated nerve revealed
accumulation of syd on both sides of the ligature (Figure 2A), as reported previously [3].
Proteins identified in the small syd vesicle population, SNAP29 and Synaptotagmin VII,
accumulated mostly proximal to the ligation site, indicative of anterograde axonal
transport, as predicted (Figure 2A, 2B). In contrast, proteins identified on the large syd
vesicle population, such as VAMP3/cellubrevin and syntaxin 13, accumulated on both
proximal and distal sides, indicative of bidirectional transport (Figure 2B, 2D). Our
results indicate that morphologically and biochemically distinct syd vesicles display
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distinct axonal transport properties. Small syd vesicles primarily travel in the anterograde
direction, and syd-endosomes may travel bidirectionally, consistent with the presence of
both kinesin and dynein-dynactin on these vesicles, and with previous observations that
early/recycling endosomes travel bidirectionally along axons of culture neurons [17,18].
Together, these findings suggest that the two distinct pools of syd vesicles may play
different roles in axonal growth, maintenance, or repair.
In vivo co-localization of syd with endosomes—Previous immuno-EM analyses
in sciatic nerve indicated that syd localizes to multivesicular organelles on the distal side
of a ligation [3], but these experiments did not demonstrate whether these organelles
belong to the endocytic pathway. To address whether syd plays a role in endosomal
trafficking along axons in vivo, we labeled the endocytic pathway in peripheral nerves
and examined syd co-localization with labeled endosomes by fluorescence microscopy.
We labeled the endocytic pathway in sensory neurons by subcutaneous injection of the
endocytic tracer Texas Red dextran in the mouse rear leg footpad. Nerves are able to take
up tracers at the sensory terminals and transport them retrogradely along axonal tracts to
the cell body in the dorsal root ganglia. We performed a sciatic nerve ligation
concomitant with dye injection to increase the number of labeled structures accumulating
distal to the ligation site. The sciatic nerve was analyzed 24 hours after injection. Distal
to the ligation site, axons labeled with Texas Red dextran contained syd (Figure 3A). In
contrast, proximal to the ligation site, no dextran was detected, but syd accumulated, as
expected (Figure 2A, 3A) [3].
When examined at higher magnification (Figure 3B) or by confocal microscopy
(Figure 3C) followed by deconvolution, Texas Red dextran-positive structures partially
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co-localized with syd within single axons. Structures positive for syd and Texas Red
dextran also partially co-localized with the endosomal marker VAMP3 [19] (Figure 3D),
which we found associated with large syd vesicles. These results indicate that syd resides
at least in part on axonal endosomes. However, the exact nature of the labeled endosomes
awaits further investigation at the EM level. Together, our findings further our previous
observations and show that syd associates with two distinct axonal vesicle populations,
thereby shedding light on the function of syd in both development and regeneration.

98

DISCUSSION
Our data suggest that syd vesicles represent a population of bidirectional
early/recycling endosomes that utilize kinesin-1 and dynein-dynactin for transport along
the axon. Movement of endosomes in axons was thought to be exclusively retrograde
[19], but other studies have shown bidirectional movement of recycling endosomes
[20]and late endosomes/lysosomes [21]. More recently, live imaging experiments in
cultured neurons revealed that the anterograde transport of endosomes mediates targeting
of the adhesion molecule L1/Cam to the axon [18]. L1/Cam is present in large syd
vesicles [16], suggesting that a syd-dependent recruitment of kinesin to endosomes may
mediate L1/Cam transport to the axon. syd may represent a regulatory switch for motor
proteins of opposing direction that controls trafficking of endocytic vesicles along the
axon because the binding sites for kinesin and dynactin are mutually exclusive [22].
At the ligation site, syd-endosomes may contribute to local membrane trafficking
events including exo- and endocytosis. Indeed, several studies have shown that exo- and
endocytosis are required for plasma membrane repair in epithelial cells [23] [24].
Although the endocytic pathway in epithelial cells is well characterized, the molecular
machinery mediating endosomal trafficking in neurons is still poorly understood.
Nonetheless, the emerging picture of endosomal trafficking in neurons suggests that
different endosomal pools may be involved in the regulation of distinct signaling
pathways and polarized distribution of guidance and adhesion molecules [25].
The retrograde transport of endosome/multivesicular bodies (MVBs) is believed
to represent the organelle that carries neurotrophic factors in axons. Although the brainderived neurotrophic factor TrkB receptor was identified on syd vesicles [16], our data do
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not allow us to establish whether syd mediates the retrograde transport of the classical
neurotrophin-signaling endosome. Furthermore, the role of MVBs in retrograde signaling
endosomes in axons has been recently challenged [26], and MVBs may instead represent
a population of organelles that arises upon injury in axons. Indeed, the retrograde
transport of MVBs may play a role in injury signaling. Storage of signaling molecules
within intralumenal vesicles of multivesicular bodies may prevent their deactivation
during the long journey from the axon back to the cell body [27]. Intralumenal vesicles
are not always destined for lysosomal degradation; they can also fuse back with the
limiting membrane of late endosomes [28]. This process is hijacked by several toxins and
viruses to reach the cell body and could similarly be exploited by signaling proteins [28].
For example, storage of phosphorylated proteins within intralumenal vesicles may allow
effective long range signaling in neurons and may play an important role in nerve
regeneration.
The precise nature and function of the small syd vesicles await further studies.
However, the presence of adhesion and cytoskeletal regulatory proteins as well as
ribosomal proteins [16], together with the observation that small syd vesicles mainly
travel in the anterograde pathway [3] lead us to propose that small syd vesicles may play
a role in neurite outgrowth and guidance. This hypothesis is supported by the axonal
growth defects observed in syd knock-out animals [14,15]. Another link between syd
and axonal growth and guidance comes from C. elegans studies. UNC-14, a protein
required for axonal elongation and guidance, interacts with syd/UNC-16 [29]. If small
syd vesicles play a role in axonal outgrowth during development, they may serve a
similar role during nerve repair and regeneration. Synaptotagmin VII, a member of the
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synaptotagmin family of Ca2+-binding proteins, was identified in small syd vesicles.
Synaptotagmin VII mediates exocytosis of lysosomes, a process important for the repair
of plasma membrane wounds [24] and for neurite outgrowth [30].
In summary, we have uncovered the molecular anatomy of two distinct classes of
syd-associated vesicles. Our studies point to a role for endocytic syd vesicles in the
transport of signals along the axon and in the recycling of synaptic vesicles. In addition,
syd may play a role in axonal growth and guidance through its interaction with another
class of small anterograde vesicles. The identification of syd vesicle protein composition
should contribute to define the mechanisms regulating axonal growth, guidance, and
repair.
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MATERIALS AND METHODS
Antibodies and Reagents- syd antibodies were previously described [10]. We used the
following antibodies: anti-tubulin DM1A (Sigma), anti-amyloid precursor protein
(Chemicon), anti-syntaxin 13, anti-SNAP29, anti-synaptotagmin VII, and anticellubrevin/VAMP3 (Synaptic Systems), Alexa Fluor-labeled secondary anti-mouse and
anti-rabbit antibodies (Invitrogen). Texas Red dextran 3000 MW was purchased from
Invitrogen.
Sciatic Nerve Ligation- Sciatic nerve ligation experiments were performed as described
previously [3]. Briefly, the sciatic nerves of mice were ligated unilaterally at the midpoint,
and mice were sacrificed at the indicated time after surgery. To avoid contamination of
proximal and distal parts, two ligations were placed 1 mm apart. Sciatic nerves were
dissected 6 hours following ligation. For biochemistry, equal lengths of the proximal and
distal parts were homogenized in sample buffer, and equal protein amounts were loaded
and analyzed by SDS-PAGE and Western blotting. The tubulin Western blot serves as
loading control. For in vivo labeling of the endocytic pathway, two ligations were placed
1 mm apart, the nerve was sectioned in between the two knots, and 5 μl of 20 mg/ml
Texas Red dextran 3000 MW was injected in the rear leg footpad. All surgeries were
performed using adult female C57/bl6 mice and anesthetized with isofluorane. The sciatic
nerve was dissected 24 hours following ligation and dextran injection. All procedures
were approved by the Washington University in St. Louis, School of Medicine, Animal
Studies Committee.
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Immunofluorescence- Sciatic nerves were dissected and postfixed 2 h in 4%
paraformaldehyde in PBS. Nerves were incubated overnight in 20% sucrose, embedded
in Tissue-Tek OCT medium, and frozen in dry ice-cooled methanol. Serial 10-μm
cryostat sections were cut and mounted onto coated slides (Fisher Scientific). Sections
were permeabilized and blocked with 10% goat serum, 0.1% Triton X-100 in PBS, or 5%
fish skin gelatin, 0.3% Triton X-100 in PBS for 30 min. Sections were incubated with the
indicated primary antibodies overnight at 4 °C and with Alexa Fluor-conjugated
secondary antibodies for 3 h. For low resolution images, sections were observed with a
×20 objective on a Nikon TE2000. For high resolution images, sections were observed
with a ×100 objective on an Olympus FV500 confocal microscope or a Nikon Optigrid
and deconvolved using Metamorph software.
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Figure 1. syd interacts with two types of vesicles of distinct size and morphology.
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Figure 1. syd interacts with two types of vesicles of distinct size and morphology.
Electron microscopy analyses of immunoisolated syd vesicles reveal larger (left) and
smaller (right) vesicle types. Both single membrane vesicles (arrowheads) and tubules
(arrows) were found.
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Figure 2. Axonal transport of syd vesicle components.
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Figure 2. Axonal transport of syd vesicle components. Sciatic nerves were ligated
unilaterally at the midpoint and processed for immunofluorescence microscopy or SDSPAGE and Western blot analysis 6 hours later. (A) syd accumulates on both the proximal
and the distal side of the ligation site, as expected. Ab, antibody. (B) Ligated and
contralateral unligated sciatic nerves were dissected and extracts were analyzed by
Western blot with the indicated antibodies. SNAP29 and synaptotagmin VII (SytVII),
two proteins identified on the small syd vesicles, accumulated mostly on the proximal
side, indicative of anterograde transport. Low levels are also detected to some extent on
the distal sides, similarly to amyloid precursor protein (APP), a well established
anterograde marker. The synaptotagmin antibody recognizes several isoforms, as
indicated. Syntaxin 13, identified on the large syd vesicles, was detected on both the
proximal and the distal sides, indicating that these proteins are transported in both
anterograde and retrograde directions. Tubulin is used as a loading control. Ul, unligated;
P, proximal; D, distal. C and D, SNAP29 and synaptotagmin VII are found mostly on the
proximal side (C), and syntaxin 13 and VAMP3 are found on both sides (D), similarly to
syd. In (A), (C), and (D), bar = 100 μm.
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Figure 3. syd localization with in vivo labeled endosomes.
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Figure 3. syd localization with in vivo labeled endosomes. The endocytic pathway
within sensory neurons was labeled by subcutaneous injection of the tracer Texas Red
dextran in the mouse rear leg footpad. A sciatic nerve ligation concomitant with dye
injection was performed to increase the number of labeled structures accumulating distal
to the ligation site. The sciatic nerve was dissected 24 h after injection, fixed, and
embedded in cryomold. Longitudinal sections were analyzed by immunofluorescence.
(A) Low magnification images showed syd accumulation in Texas Red dextran (TR
dextran)-positive axons (arrowheads). (B) and (C), Nikon Optigrid structured
illumination microscopy (B) or confocal microscopy (C) followed by deconvolution
showed that Texas Red dextran puncta partially co-localize with syd. Three consecutive
sections in the z plane are shown in (B) (D) Triple immunostaining showed that syddextran-positive structures also contained the endosomal protein VAMP3/cellubrevin,
further supporting the notion that syd resides at least in part on axonal endosomes. (A)
bar = 100 μm; (B), (C), (D)= 5 μm.
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Chapter 5: Sciatic nerve injury induces mTOR activation in Schwann cells

Contributions: Semithin sectioning and staining was performed by Howard Wynder at the
Developmental Biology Histology Core
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ABSTRACT
The response of Schwann cells to peripheral nerve injury play an integral role in
nerve repair by creating a permissive environment for regeneration. While the
morphological and functional responses that occur in Schwann cells following peripheral
nerve injury have been characterized, the signaling pathways that mediate these events
are not well known. We find that components of the mTOR pathway, Akt and S6
ribosomal protein are rapidly phosphorylated in Schwann cells within minutes to hours
following sciatic nerve injury. Injury-induced S6 phosphorylation is abolished by
rapamycin, indicating that mTOR is active following damage. Akt phosphorylation is
concentrated at the paranode and spreads asymmetrically down the length of the node. In
contrast, S6 phosphorylation occurs in the perinuclear space. Mechanical trauma to
purified Schwann cells in vitro is not sufficient to activate Akt or S6 phosphorylation,
suggesting that reciprocal signaling between axons and Schwann cells is important for the
activation of this pathway.
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INTRODUCTION
Successful regeneration depends upon not only intrinsic injury signals, but also on
extrinsic factors in the environment. In the peripheral nervous system, Schwann cells act
not only as insulators for fast, salutatory conduction of action potentials, but also play an
essential role in the maintenance of axon health and integrity. In healthy nerves, the
relationship between axons and their myelinating Schwann cells is maintained by
contact-mediated reciprocal signaling [1]. Following injury, Schwann cells undergo a
series of molecular and morphological changes upon disruption of contact with the axons
that they myelinate [2]. These Schwann-cell mediated events play a critical role in the
response of axons to injury.
One remarkable feature of Schwann cells is their ability to reverse differentiation.
Within two days following nerve injury, Schwann cells undergo de-differentiation, or
reversion from a differentiated myelinated state to an undifferentiated, immature state [3].
Dedifferentiation occurs through downregulation of myelination genes, including P0,
myelin basic protein (MBP), myelin associated glycoprotein (MAG), and periaxin,
[4,5,6,7]. Concurrently, genes that are active in immature Schwann cells prior to
myelination, such as L1, neural cell adhesion molecule (NCAM), p75 low affinity
neurotrophin receptor (p75NTR) and glial fibrillary acidic protein (GFAP), become
upregulated [8]. Following nerve damage, demyelination of injured axons creates a
permissive environment for axonal regeneration [9,10]. Consistently, Schwann cellspecific deletion of c-Jun, a gene essential to drive dedifferentiation, results in a delay in
myelin sheath degradation after nerve injury, as well as a significant loss of regenerative
ability and functional recovery[11,12].
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Following demyelination, degradation of myelin and axonal debris occurs through
phagocytosis initially by Schwann cells, then later by macrophages that are recruited to
the injury site [13,14,15,16].

Phagocytosis of axon and myelin debris is critical for

degeneration of the nerve distal to the injury site, as well as for the regeneration of
proximal axons. Myelin-associated proteins such as MAGs act as a potent negative
regulators of axonal outgrowth. [17]. Thus, the removal of such inhibitory molecules by
phagocytosis is essential to create a permissive environment for regeneration [18].
Indeed, the inability of the central nervous system to efficiently remove myelin debris
following injury is linked to loss of regenerative ability [19].
Loss of axonal contact after injury also triggers Schwann cells to proliferate. As
Schwann cells divide, they form linear arrays called bands of Bungner along the empty
basement membrane of the endoneurial tube [20,21]. These bands of Schwann cells
provide a platform for the growth of new axons into the distal end of the injury. Injuryinduced proliferation of Schwann cells is mediated by a multitude of mitogenic factors
released by macrophages, axons, and Schwann cells themselves [22].
Schwann cells are also a major source of growth factors that support the survival
and growth of axons following injury. These include the neurotrophic factors NGF,
BDNF, GDNF, as well as cytokines tumor necrosis factor (TNFα) and leukemia
inhibitory factor (LIF) [23,24,25,26,27]. Such growth factors influence regeneration by
not only enhancing survival and outgrowth of neurons, but also by regulating Schwann
cell differentiation and remyelination of newly formed axons [28]. Furthermore,
Schwann cells synthesize and provide surface cell adhesion molecules (CAMs), such as
N-CAM, Ng-CAM/L1, N-cadherin, as well as basement membrane proteins such as
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laminin, collagen, and fibronectin [22]. These molecules mediate adhesion between
axons, axons and Schwann cells, and axons and the basal lamina, and thus provide
substrates for the regrowth of new axons [22].
While the molecular and morphological changes that occur in Schwann cells
following peripheral nerve injury have been documented, the signaling pathways that
initiate these events are not well known. Furthermore, most studies have focused on
events that occur days to weeks following damage, rather than early responses. Here, we
sought to determine molecular pathways that become activated in Schwann cells as an
immediate response to nerve injury. We find that Akt and S6 ribosomal protein,
components of the mTOR pathway, are rapidly phosphorylated in Schwann cells within
minutes to hours following sciatic nerve injury. Rapamycin potently blocks injuryinduced S6 phosphorylation in Schwann cells, indicative of active mTOR following
damage. We find that Akt phosphorylation is most robust at the paranode and spreads
asymmetrically down the length of the node, while S6 phosphorylation occurs in the
perinuclear region. Mechanical injury to Schwann cells in vitro is not sufficient to
activate Akt or S6 phosphorylation, suggesting that reciprocal signaling between axons
and Schwann cells is important for the activation of this pathway. Future work may shed
light on the functional relevance of the mTOR pathway in Schwann cells in their
response to nerve damage.
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RESULTS
Akt and S6 ribosomal protein, components of the mTOR pathway, are rapidly
phosphorylated in Schwann cells following injury- To identify signaling events that
occur locally in the sciatic nerve following injury, we dissected the sciatic nerve 5mm
proximal and distal to the ligation site at various time points after injury. Western
blotting of unligated and ligated sciatic nerve extract revealed phosphorylation of Akt at
Serine 473 as early as 15 minutes after ligation (Figure 1A, 1B). Akt phosphorylation
levels peaked at 1 hour following injury, and returned to basal levels 9 hours later (Figure
1A, 1B). We also observed phosphorylation of S6 ribosomal protein at Serine 240/244,
whose upstream kinase S6 kinase is activated by mTOR (Figure 1A, 1C). S6
phosphorylation was also observed within 15 minutes after ligation, but unlike Akt
phosphorylation, steadily increased and persisted for at least 10 hours following injury
(Figure 1A, 1C). Immunostaining of longitudinal sciatic nerve sections using phosphoAkt and phospho-S6 antibodies revealed that phosphorylation of these proteins occurs
both proximal and distal to the ligation site (Figure 1D).
Akt and S6 ribosomal proteins are upstream and downstream components of the
mTOR pathway, respectively. Injury-induced phosphorylation of S6 was completely
abolished by intraperitoneal injection of the mTOR inhibitor rapamycin, indicating that
mTOR activity is responsible for this phosphorylation event (Figure 1E). Intraperitoneal
injection of the PI-3-kinase inhibitor LY294002 failed to inhibit the injury-induced
phosphorylation of Akt. Thus, we have yet to determine whether Akt activation in the
sciatic nerve following injury contributes to mTOR activity or to mTOR-independent
pathways.
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To determine whether injury-induced phosphorylation of Akt and S6 occur in
axons or in surrounding Schwann cells, we performed immunohistochemical analyses on
ligated sciatic nerve cross-sections. Phosphorylation of Akt in the unligated nerve occurs
mostly in axons (Figure 2). However, in ligated sciatic nerve cross-sections, the majority
of phospho-Akt signals overlap with the s100 Schwann cell marker, indicating that the
increase in Akt phosphorylation levels after injury occurs in Schwann cells (Figure 2).
Similarly, we found a marked increase in S6 phosphorylation levels in Schwann cells in
ligated sciatic nerve cross sections (Figure 2). These results indicate that sciatic nerve
injury induces phosphorylation of Akt and S6 in Schwann cells after injury.
Subcellular localization of Akt and S6 phosphorylation- To examine the
subcellular localization of injury-induced Akt and S6 phosphorylation within Schwann
cells, we performed immunohistochemical analyses on teased sciatic nerve preparations
in which individual axons and their myelinating Schwann cells are laid flat on a twodimensional surface. At low magnification, we observed that Akt phosphorylation is
most concentrated near nodal regions and spreads unidirectionally down the internode
away from the ligation site (Figure 3A, 3B). As contact-mediated reciprocal signaling
between axons and Schwann cells occurs at the paranode [29] [1], we suspected that Akt
phosphorylation may be concentrated at these sites. High-magnification confocal images
of teased nerve sections stained for p-Akt and Caspr, a paranodal marker [29], confirmed
that Akt phosphorylation occurs at the paranode on both sides of the node (Figure 3B).
As observed in the low magnification images, the spread of Akt phosphorylation down
the internode was detected only on one side of the node (Figure 3B, 3D). In marked
contrast, phosphorylated S6 ribosomal protein is concentrated near the perinuclear
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regions, consistent with the role of this protein in recruitment of ribosomes to mRNA
(Figure 3C).
Mechanical injury to Schwann cells in vitro is not sufficient to activate Akt and
S6 ribosomal protein- To better understand how the mechanism by which nerve injury
activates Akt and S6 in Schwann cells, we tested whether mechanical injury to Schwann
cells is sufficient to trigger phosphorylation of these proteins. We cultured Schwann cells
from rat postnatal sciatic nerves and crushed them with a flathead instrument to induce
mechanical injury. Mechanical injury to purified Schwann cells in vitro was not
sufficient to activate Akt or S6 ribosomal protein, indicating that that reciprocal signaling
between axons and Schwann cells may be required for the activation of this pathway
(Figure 4).
mTOR activity is not required for demyelination- To explore whether activation
of the mTOR pathway in Schwann cells have a functional role in their response to injury,
we tested whether inhibition of mTOR activity by rapamycin could block demyelination
of damaged axons. We chose to examine demyelination as a potential function of the
mTOR pathway, as this process is one of the earlier events that occur in Schwann cells
after damage and correlates temporally with the observed mTOR activation. We injected
mice with either DMSO or rapamycin one hour prior to sciatic nerve ligation, dissected
the sciatic nerve 48 hours later, and performed toluidine blue staining on semithin
sections to visualize myelin sheaths. The degree of disorganization and unwinding of
myelin sheaths was not markedly different between DMSO and rapamycin-treated ligated
nerves, suggesting that mTOR activity in Schwann cells is dispensable for demyelination

121

after injury (Figure 5). Further studies will be required to determine the function of
mTOR activity in Schwann cells in their response to damage.
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DISCUSSION
While the morphological and functional responses of Schwann cells to peripheral
nerve injury has been observed, little is known about the molecular pathways that
mediate these processes. We find that the mTOR pathway becomes activated in Schwann
cells as early as 15 minutes following sciatic nerve injury. We observed robust
phosphorylation of S6 ribosomal protein which can be blocked by the mTOR inhibitor,
rapamycin. Akt, one of the upstream regulators of mTOR activity, is also rapidly
phosphorylated and activated in Schwann cells after injury. However, we have yet to
determine whether Akt activity in Schwann cells contributes to mTOR activation, or
whether it acts on other downstream targets independent of the mTOR pathway. We
attempted to test this by pharmacological inhibition of Akt activation, but intraperitoneal
injection of PI3-kinase inhibitor LY294002 did not successfully inhibit Akt activation.
Other PI3-kinase inhibitors such as Wortmannin, or direct application of the drug into the
nerve may be more effective in inhibiting kinase activity in vivo. As we observed in
injured DRG neurons, it is possible that mTOR activation is occurring through Aktindependent mechanisms. Furthermore, the distinct subcellular localization of Akt and
S6 phosphorylation suggests that activity of these proteins may have independent
functions.
The concentration of p-Akt near the paranode in injured nerves indicate that
reciprocal signaling between axons and Schwann cells may play an integral role in the
activation of this protein. We found that mechanical trauma to purified Schwann cells in
vitro is not sufficient to activate Akt or S6 phosphorylation, consistent with the idea that
the intricate morphological and biochemical interaction between axons and Schwann
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cells is critical for these signaling events. It would be interesting to test whether axotomy
of myelinated axons in Schwann cell-DRG co-cultures could induce activation of Akt or
S6. Our in vivo analyses of the subcellular localization of Akt phosphorylation revealed
that the spread of Akt phosphorylation down the internode occur unidirectionally away
from the injury site. In our teased nerve preparations, we could observe only a few nodes
in a given nerve fiber. Preparations of longer nerve fibers may allow us to track the
pattern of Akt phosphorylation in multiple nodes along a given fiber, which could
provide better insight on the mechanism and relevance of the asymmetric nature of this
signal.
To determine the functional relevance of mTOR activation in Schwann cells in
their response to injury, we tested whether mTOR is required for demyelination of
damaged axons. Rapamycin failed to block disorganization and unwinding of myelin
sheaths, indicating that mTOR may not contribute to demyelination. As demyelination is
tightly coupled with dedifferentiation, we speculate that dedifferentiation also does not
require mTOR activity. Due to caveats of pharmacological experiments, genetic ablation
of mTOR activity in Schwann cells will be necessary to confirm that this pathway is
dispensable for dedifferentiation and demyelination after injury.
One potential function of the mTOR pathway in Schwann cells after peripheral
nerve injury is phagocytosis of myelin and axonal debris. Akt has been implicated to
mediate phagocytosis in macrophages through its activation of the mTOR pathway.
Overexpression of constitutively-active Akt in macrophages in vitro increases efficiency
of phagocytosis, while inhibition of mTOR by rapamycin blocks this effect. [30].
Furthermore, recent reports have implicated the mTOR pathway in the regulation of actin
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dynamics through cdc42 and rac1 [31]. As remodeling of the actin cytoskeleton by
cdc42 and rac1 is essential for phagocytosis [32], it is possible that mTOR activity in
Schwann cells contributes to this process. To test this possibility, electron microscopic
analyses will be required to visualize phagocytosis of debris by Schwann cells in the
injured nerve in vivo. Phagocytosis could also be assayed in vitro using cultured
Schwann cells; however, we would first need to identify signals or ligands that could
activate phagocytosis in Schwann cells in vitro.
mTOR activation in Schwann cells may also contribute to protein synthesis.
After sciatic nerve injury, Schwann cells synthesize and release a number of proteins that
support survival and regeneration, including growth factors and extracellular matrix
proteins [22,23,24,25,26,27]. Given the role of mTOR in ribosomal recruitment and
protein translation, [33], it is possible that mTOR activity contributes to protein synthesis
after injury. It would be interesting to test whether inhibition of mTOR activity by
pharmacology or genetics could inhibit this process. As many of these proteins are
soluble, immunodetection by ELISA may be required to assess changes in the levels of
these Schwann-cell synthesized molecules.
It is possible that Akt activity after nerve injury has a distinct function
independent of mTOR regulation. The concentration of p-Akt in paranodes in the injured
nerve resembles the localization of p-ErbB2 [34]. Phosphorylation of ErbB2 is necessary
and sufficient for demyelination after peripheral nerve injury [35]. Additionally,
myelination of axons during development is regulated by reciprocal signaling between
axons and Schwann cells, and requires ErbB2 and Akt activity [36]. In vitro studies
show that Akt phosphorylation occurs downstream of ErbB2 activity [37]. As the
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timecourse of ErbB2 phosphorylation after injury correlates with the timecourse of Akt
phosphorylation, it is possible that Akt phosphorylation acts downstream of ErbB2
activation in Schwann cells after injury. As rapamycin does not block demyelination,
ErbB2 and Akt may be regulating demyelination through other downstream effectors.
Interestingly, ErbB2 phosphorylation occurs distal, but not proximal to the ligation site,
while Akt phosphorylation occurs on both sides. Thus, it is possible that Akt activation
has distinct roles on the two sides of the injury.
We speculate that cross-talk between axons and its myelinating Schwann cells is
essential both for injury signaling and in the regenerative response. Understanding the
molecular pathways that mediate Schwann cell response to injury, the mechanism by
which they are activated, and their functional relevance could shed light on how
environmental cues cooperate with intracellular growth pathways for successful
regeneration.
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MATERIALS AND METHODS
Antibodies and reagents- The following antibodies were used: anti-phosphorylated Akt
(S473) (Cell Signaling), anti-Akt (Cell signaling), anti-phosphorylated S6 ribosomal
protein (Cell Signaling, Serine 240/244), anti-S6 ribosomal protein (Cell Signaling), antiα−tubulin (Sigma), anti-SMI-31(Sternberger Monoclonals Incorporated), anti-s100
(Sigma), anti-Caspr monoclonal (gift from Elior Peles).
Surgical procedures and drug treatment- All surgical procedures were approved by the
Washington University in St. Louis, School of Medicine, Animal Studies Committee.
Adult female Sprague-Dawley rats were used for experiments involving
immunohistochemistry with anti-Caspr antibody. Adult female C57B6 mice were used
for all other experiments. Sciatic nerve injury experiments were performed as described
previously [38]. Briefly, the sciatic nerves of mice were ligated at mid-thigh at two points
1 mm apart. Mice were sacrificed indicated time after surgery and unligated and ligated
nerves 5mm proximal and distal to the ligation site were dissected. For biochemical
analyses, nerves were homogenized in lysis buffer (20mM Tris-HCl pH 7.5, 150mM
NaCl, 1mM Na2EDTA, 1mM EGTA, 1% Triton, 2.5mM sodium pyrophosphate, 1mM βglycerophosphate, 1mM Na3VO4, 1μg/ml leupeptin) with phosphatase inhibitor cocktail 1
and 2 (Invitrogen). Equal protein amounts were loaded and analyzed by SDS-PAGE and
western blot.
Rapamycin was delivered by intraperitoneal injection at 5mg/kg body weight.
Rapamycin was dissolved in 200 μl DMEM from a 10 mg/ml stock solution in DMSO.
An equivalent volume of DMSO was dissolved into 200 μl DMEM for vehicle control.
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Intraperitoneal injection was performed 1 hr before sciatic nerve ligation. Animals were
sacrificed and nerves were dissected 48 hours following ligation.
Schwann cell culture and immunofluorescence-. For Schwann cell cultures, sciatic
nerves were dissected from P3 Sprague-Dawley rats and incubated in 0.1% collagenase
in DMEM at 37º C for 30 minutes. Cells were collected by centrifugation at 800g for 10
minutes, washed, and resuspended in D-media (DMEM, 10% FBS, 2mM glutamine, 1%
Pen/Strep) onto laminin-coated tissue culture flasks. After two passages, Schwann cells
were purified by complement-killing of fibroblasts with anti-Thy1.1 antibody (Serotec).
Purified Schwann cells were plated onto laminin-coated plastic dishes and maintained in
D-media. For immunofluorescence staining, cells were fixed in 4% PFA/PBS for 30
minutes, then permeabilized and blocked in 10% Goat Serum, 0.1% Triton-X in PBS for
15 minutes. Staining was performed with the indicated primary antibodies for 30 minutes
at room temperature, and with Alexa-conjugated secondary antibodies for 20 minutes.
Images were acquired with Nikon Eclipse TE2000-E inverted microscope and analyzed
using Nikon NIS Elements Advanced Research 2.30 Imaging Software.
Immunohistochemistry- For preparation of frozen sections, ligated and unligated sciatic
nerves were dissected and fixed for 1-2 hours in 4% PFA in PBS, cryoprotected
overnight in 20% sucrose, and embedded in OCT (Tissue-Tek) and frozen in dry-icecooled methanol. 10-µm serial cryostat sections were cut and mounted onto coated slides
(Fisher Scientific). For teased nerve preparations, ligated and unligated sciatic nerves
were dissected, fixed for 10 minutes in 4% PFA in PBS, and washed with PBS. After the
perineurium was removed, nerves were manually teased apart in PBS with forceps, then
transfered onto coated slides with a drop of PBS. Nerves were dried overnight at room
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temperature and frozen at -80ºC until used for immunostaining. Frozen cryostat sections
and teased nerve fibers were permeabilized and blocked with 10% goat serum, 0.1%
Triton X-100 in PBS for 30 min. Primary staining with the indicated antibodies was
performed in the blocking solution overnight at 4ºC. Staining with Alexa-conjugated
secondary antibody was performed for 1 to 3 hours. Images were acquired with Nikon
Eclipse TE2000-E inverted epifluorescence microscope or Olympus 500 confocal
microscope and analyzed using Metamorph 6.2.
Semithin sections and toluidine blue staining- Fixation of nerve, embedment,
sectioning, and toluidine blue staining were performed by Howard Wynder at the
Developmental Biology Histology Core. Nerves were fixed in 4% PFA/2.5%
gluteraldehyde/0.1M cacodylate buffer overnight at 4ºC, followed by wash with 0.1M
cacodylate buffer. Secondary fixation in 1% Osmium Tetroxide was performed for 1
hour at room temperature, followed by wash with 0.1M cacodylate wash. Nerves were
then dehydrated in 50% ethanol for 15 minutes, 70% ethanol for 30 miutes, 95% ethanol
for 45 minutes, then 100% ethanol for 1 hour. Following dehydration, nerves were
incubated in propylene oxide for 30 minutes, then in a 1:1 mixture of propylene oxide
and Epon overnight at room temperature. The next day, nerves were incubated in freshly
prepared Epon for several hours, then placed in another batch of fresh Epon for
embedment at 65ºC overnight. Nerves were sliced into .5 to 1μm semithin sections using
Leica Ultramicrotome and stained with toluidine blue.
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Figure 1. Akt and S6 ribosomal protein are phosphorylated in sciatic nerve
following injury.
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Figure 1. Akt and S6 ribosomal protein are phosphorylated in sciatic nerve
following injury. (A) Unligated and ligated sciatic nerves 5mm distal and proximal to
the ligation site were dissected at the indicated time points following ligation, and Akt
and S6 phosphorylation levels were assessed by western blot. One mouse was used per
time point. Akt and S6 phosphorylation were detected as early as 15 minutes following
ligation. Quantification of Akt phosphorylation (B) and S6 phosphorylation (C) were
based on 3 independent experiments. * p<0.05, data are mean +/- SEM (Student’s t-test).
(D) Immunohistochemistry on longitudinal sections of unligated nerve and ligated nerve
6 hours following ligation reveal Akt and S6 phosphorylation occur on both proximal and
distal sides of the ligation. Bar=50μm. (E) Mice were injected intraperitoneally with
rapamycin or DMSO vehicle control one hour prior to sciatic nerve ligation, and sciatic
nerves were dissected 6 hours following ligation. Rapamycin treatment abolishes S6
phosphorylation in the ligated sciatic nerve.
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Figure 2. Injury-induced phosphorylation of Akt and S6 ribosomal protein occurs
in Schwann cells.
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Figure 2. Injury-induced phosphorylation of Akt and S6 ribosomal protein occurs
in Schwann cells. Cross sections of unligated nerve or ligated nerve 2mm distal to the
ligation site were stained with s100 Schwann cell marker and (A)p-Akt or (B)p-S6
antibody. Nerves were dissected 6 hours following ligation. (A) Basal Akt
phosphorylation is detected in axons, (arrows), but injury-induced phosphorylation of Akt
occur predominantly in Schwann cells (arrowheads). (B) S6 phosphorylation in the
ligated nerve occurs in Schwann cells (arrowheads). Bar=100μm.
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Figure 3. Subcellular localization of Akt and S6 phosphorylation.
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Figure 3. Subcellular localization of Akt and S6 phosphorylation. Teased nerve
preparations from ligated nerve distal to the ligation site were stained with the indicated
antibodies. Sciatic nerves were dissected 6 hours following ligation. (A) Akt
phosphorylation occurs near nodal regions and spreads asymmetrically down the
internode away from the ligation site. (B) p-Akt signal overlaps with paranodal marker
Caspr, indicating that Akt phosphorylation occurs at the paranode on both sides of the
node. Spread of the p-Akt signal down the internode occurs only on one side. (C) S6
phosphorylation occurs in the perinuclear region surrounding that DAPI stain. (D)
Schematic of pattern of Akt and S6 phosphorylation in Schwann cells following injury.
Each axonal internode is myelinated by one Schwann cell. Akt phosphorylation occurs at
the paranode on both side of the node, but the spread of this signal down the internode
occurs unidirectionally away from the ligation site. This pattern occurs both proximal
and distal to the ligation. (Α), (Β), (C) Bar=10μm
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Figure 4. Mechanical injury to Schwann cells in vitro is not sufficient to induce Akt
and S6 phosphorylation.
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Figure 4. Mechanical injury to Schwann cells in vitro is not sufficient to induce Akt
and S6 phosphorylation. Schwann cells from P3 rat sciatic nerves were plated and
crushed in vitro and fixed 1 or 6 hours later. No significant increase in Akt or S6
phosphorylation was detected in crushed Schwann cells. Bar=50μm.
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Figure 5. mTOR activity is not necessary for demyelination following injury.
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Figure 5. mTOR activity is not necessary for demyelination following injury. Mice
were injected intraperitoneally with DMSO vehicle control or rapamycin one hour prior
to sciatic nerve axotomy. Unligated nerve and ligated nerve ~2mm distal to the ligation
site were dissected 48 hours following ligation. Toluidine blue staining of semithin
sections reveal no significant difference in demyelination between DMSO and rapamycin
treated ligated nerves.
Bar=50μm.
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Chapter 6: Conclusions and future directions
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Injury to the central nervous system (CNS) results in permanent loss of neuronal
function due to the inability of injured axons to regenerate. In contrast, neurons in the
peripheral nervous system (PNS) can extend new axons and reinnervate their targets
following injury. Successful regeneration depends upon a balance between extrinsic
factors in the environment and the intrinsic growth capacity of the injured neuron. The
absence of glial-derived inhibitory cues in the PNS environment has been strongly linked
to the regenerative ability of PNS neurons. However, much less is known about the
intrinsic signaling pathways activated after PNS injury to promote axonal regrowth.
One potential regulator of growth capacity in injured neurons is the mTOR
pathway. In non-neuronal cells, this pathway is active during development and is
essential for cellular growth, proliferation, and survival [1] [2]. In the CNS,
downregulation of mTOR activity following injury is linked to their lack of regenerative
ability [3]. In contrast to CNS neurons, we found that dorsal root ganglia (DRG) in the
PNS activate the mTOR pathway upon axonal damage, and that mTOR activation is both
necessary and sufficient to enhance axonal growth capacity. Furthermore, we found that
mTOR activation increases the expression of the growth-associated protein GAP-43,
suggesting that mTOR-dependent protein synthesis contributes to enhance regeneration
of injured peripheral neurons. However, overexpression of GAP-43 alone is not
sufficient to fully stimulate regrowth of central branch axons to the level of a
preconditioning injury, suggesting that the mTOR pathway regulates the translation of
additional proteins to maximize axonal growth capacity [4]. Quantitative mass
spectrometry analyses between wild-type and TSC2-deficient DRGs may reveal other
proteins whose expression is regulated by mTOR.
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Injury-induced activation of the mTOR pathway in PNS neurons demonstrate that
the ability of PNS neurons to regenerate is not merely due to the lack of inhibitory cues in
the environment, but also due to the active initiation of intracellular mechanisms that
enhance growth capacity. Downregulation of this pathway by injured CNS neurons
underscores the link between the mTOR pathway and intrinsic growth ability. To better
understand the differences between CNS and PNS neurons in their ability to activate
mTOR after injury, it will be important to identify the upstream regulators of mTOR that
are activated by PNS injury. Our data suggest that activation of mTOR in injured DRGs
occurs through Akt- and TSC2-independent mechanisms. Other candidate upstream
regulators of mTOR include phosphatidic acid, and the JAK-STAT signaling pathway.
[5] [6].
Activation of the mTOR pathway presents a promising therapeutic strategy to
facilitate regeneration of both CNS and PNS neurons. However, we found that TSC2
deletion and persistent mTOR activation in DRGs leads to major developmental and
functional defects, including increased mortality, small size, early death, sensory
impairments, and aberrant target innervation and axon morphology. Though we have not
yet tested whether re-innervation of injured axons is affected by TSC2 deletion, these
developmental defects suggest that prolonged elevation of mTOR activity may also
interfere with axon targeting and functional recovery of regenerating axons. Thus, while
manipulation of mTOR activity could stimulate regrowth of injured axons, fine control of
mTOR activity may be required for proper target innervation and functional recovery.
Alternatively, understanding the precise mechanism by which mTOR regulates growth
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versus axon targeting and morphology may offer more specific strategies on enhancing
axonal regrowth without interfering with innervation.
For the injured neuron to activate molecular changes in the cell body such as the
enhancement of intrinsic growth capacity or the activation of regeneration-associated
genes, the cell body must first receive accurate information about the site and extent of
axonal damage. Microtubule-based retrograde transport of locally activated injury
signals has been proposed to contribute to this process. For example, JNK scaffolding
protein Sunday driver (syd) has been shown to link vesicular axonal transport to injury
signaling [7]. In naive nerves, syd binds to both kinesin for anterograde transport and
dynactin for retrograde transport. Following sciatic nerve injury, JNK is locally activated
and activated JNK and syd are transported mainly retrogradely [7]. The retrograde
transport of JNK after injury is mediated by an enhanced interaction between syd and the
dynactin complex [7].
To better understand syd function in axonal transport and injury signaling, syd
vesicles were immunoisolated and analyzed by electron microscopy and massspectrometry. These studies have revealed two classes of syd-associated vesicles of
distinct morphology and protein composition, and suggested that one class of syd vesicles
belongs to the endocytic pathway, while another may belong to an anterogradely
transported vesicle pool. Here, we validated these findings by examining the localization
and transport of syd vesicle components within the sciatic nerve. Our results lead us to
propose that the endocytic syd vesicles function to carry injury signals back to the cell
body, whereas anterograde syd vesicles may play a role in axonal outgrowth and
guidance. Genetic ablation of syd in DRGs will be necessary to test whether syd-
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dependent axonal transport is essential for peripheral nerve regeneration. Furthermore,
removing the expression of proteins that specifically interact with a specific class of syd
vesicles may elucidate the distinct role of these two types of axonal organelles.
In addition to the activation of intracellular injury signaling pathways, regrowth of
peripheral neurons is guided by Schwann cells in the PNS environment that create a
permissive environment for axon regeneration. We found that components of the mTOR
pathway, Akt and S6 ribosomal protein, are rapidly phosphorylated in Schwann cells
within minutes to hours following sciatic nerve injury. Injury-induced S6
phosphorylation in Schwann cells was abolished by rapamycin, indicating that mTOR is
active following damage. Mechanical trauma to purified Schwann cells in vitro was not
sufficient to activate Akt or S6 phosphorylation, suggesting that reciprocal signaling
between axons and Schwann cells is important for the activation of this pathway.
While the morphological and functional responses that occur in Schwann cells
following peripheral nerve injury have been described, the signaling pathways that
mediate these events are not well known. Thus, it will be valuable to determine the
function of mTOR activation in Schwann cells in the context of nerve injury. In the
injured peripheral nerve Schwann cells perform a number of tasks, including demyelination, phagocytosis, proliferation, and synthesis and release of growth factors and
extracellular matrix proteins. An in vitro myelinating Schwann cell-DRG co-culture
system may offer assays to rigorously test the necessity of the mTOR pathway in each of
these processes. Furthermore, it is unknown whether these Schwann-cell mediated
events are necessary for nerve regeneration itself. If mTOR activation is required for any
of these events, genetic ablation of mTOR components in Schwann cells could provide a
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valuable tool to test the necessity of Schwann cell processes in peripheral nerve
regeneration. It is likely that that cross-talk between axons and its myelinating Schwann
cells is essential both for injury signaling and the regenerative response.
In this thesis, we explored multiple components of peripheral nerve injury
signaling: transport of local injury signals by axonal vesicles, enhancement of intrinsic
growth capacity in the cell body, and response of Schwann cells that myelinate the
damaged axon. We found that the mTOR pathway is activated in both DRGs and
Schwann cells after injury, and that in DRGs, this pathway plays an essential role in the
enhancement of axonal growth capacity. The mTOR pathway is unlikely to be the only
signal that mediates nerve regeneration; several classes of signaling pathways may act in
concert to orchestrate a robust regenerative response. In fact, recent proteomic studies
estimate that over 900 phosphoproteins and 4500 transcripts are involved in the injury
response [8]. Additionally, it is likely that extrinsic cues derived from Schwann cells also
cooperate with intracellular growth pathways for optimal regrowth. Identification of
multiple components and signaling pathways that regulate nerve regeneration in both
neurons and Schwann cells may unravel new therapeutic targets to promote PNS and
CNS recovery from injury.
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